reaction_smiles,sources,reactants,products,solvents,catalyst,stages
"['[C:1]1([C:7]#[C:8]/[CH:9]=[CH:10]/[CH2:11]O)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.P(Br)(Br)[Br:14]', 'C1(C)C=CC=CC=1.C(OCC)(=O)C', '[Br:14][CH2:11]/[CH:10]=[CH:9]/[C:8]#[C:7][C:1]1[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1']","['US20010041709A1', '0537', 'A solution of (E)-5-phenyl-pent-2-en-4-yn-1-ol (Method 1b) (980 mg, 6.2 mmol) in dry toluene (20 mL) was cooled on ice and phosphorus tribromide (0.59 mL, 6.2 mmol) added slowly. After 16 h at 5° C. the mixture was diluted with ethyl acetate and washed with water (×3). The organic phase was concentrated in vacuo and the residue extracted with heptane (×3). The combined heptane phases were concentrated in vacuo to give 900 mg of crude (E)-(5-bromo-pent-3-en-1-ynyl)-benzene. (According to NMR the product contained -5% of the (Z)-isomer).']","[{'chemical_names': ['(E)-5-phenyl-pent-2-en-4-yn-1-ol'], 'identifiers': ['smiles:OC/C=C/C#Cc1ccccc1', 'inchi:InChI=1S/C11H10O/c12-10-6-2-5-9-11-7-3-1-4-8-11/h1-4,6-8,12H,10H2/b6-2+'], 'amounts': ['6.2 mmol', '980 mg'], 'appearances': []}, {'chemical_names': ['phosphorus tribromide'], 'identifiers': ['smiles:BrP(Br)Br', 'inchi:InChI=1S/Br3P/c1-4(2)3'], 'amounts': ['6.2 mmol', '0.59 mL'], 'appearances': []}]","[{'chemical_names': ['(E)-(5-bromo-pent-3-en-1-ynyl)-benzene'], 'identifiers': ['smiles:BrC/C=C/C#Cc1ccccc1', 'inchi:InChI=1S/C11H9Br/c12-10-6-2-5-9-11-7-3-1-4-8-11/h1-4,6-8H,10H2/b6-2+'], 'amounts': ['900 mg', '65.7'], 'appearances': []}]","[{'chemical_names': ['toluene'], 'identifiers': ['smiles:Cc1ccccc1', 'inchi:InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3'], 'amounts': ['20 mL'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:A solution of (E)-5-phenyl-pent-2-en-4-yn-1-ol (Method 1b) (980 mg, 6.2 mmol) in dry toluene (20 mL) was cooled on ice and phosphorus tribromide (0.59 mL, 6.2 mmol)', 'step 2:added slowly', 'step 3:After 16 h at 5° C. the mixture was diluted with ethyl acetate', 'step 3 properties:Time:57600', 'step 3 properties:Temperature:5', 'step 4:washed with water (×3)', 'step 5:The organic phase was concentrated in vacuo', 'step 6:the residue extracted with heptane (×3)', 'step 7:The combined heptane phases were concentrated in vacuo', 'step 8:to give 900 mg of crude (E)-(5-bromo-pent-3-en-1-ynyl)-benzene']"
"['C([O:3][C:4](=O)/[CH:5]=[C:6](\\[CH3:17])/[C:7]#[C:8][C:9]1[CH:14]=[C:13]([Cl:15])[CH:12]=[C:11]([Cl:16])[CH:10]=1)C.[H-].C([Al+]CC(C)C)C(C)C.[Cl-].[NH4+].C(OCC)(=O)C', 'C1COCC1', '[CH3:17]/[C:6](/[C:7]#[C:8][C:9]1[CH:10]=[C:11]([Cl:16])[CH:12]=[C:13]([Cl:15])[CH:14]=1)=[CH:5]\\[CH2:4][OH:3] |f:1.2,3.4|']","['US20010041709A1', '0571', 'To a solution of (E)-3-methyl-5-(3,5-dichloro-phenyl)-pent-2-en-4-ynoic acid ethyl ester (130 mg, 0.46 mmol) in THF (0.5 mL) was added dropwise diisobutylaluminium hydride (1.0 M solution in toluene, 2.1 mL, 2.1 mmol) at −20° C. The reaction mixture was stirred for 2 hours at −20° C., whereafter saturated ammonium chloride was added. The mixture was treated with ethyl acetate and decalite and filtered. The filtrate was evaporated to give crude (E)-3-methyl-5-(3,5-dichloro-phenyl)-pent-2-en-4-yn-1-ol in 113 mg yield.']","[{'chemical_names': ['(E)-3-methyl-5-(3,5-dichloro-phenyl)-pent-2-en-4-ynoic acid ethyl ester'], 'identifiers': ['smiles:CCOC(=O)/C=C(\\C)C#Cc1cc(Cl)cc(Cl)c1', 'inchi:InChI=1S/C14H12Cl2O2/c1-3-18-14(17)6-10(2)4-5-11-7-12(15)9-13(16)8-11/h6-9H,3H2,1-2H3/b10-6+'], 'amounts': ['0.46 mmol', '130 mg'], 'appearances': []}, {'chemical_names': ['diisobutylaluminium hydride'], 'identifiers': ['smiles:CC(C)C[Al+]CC(C)C.[H-]', 'inchi:InChI=1S/2C4H9.Al.H/c2*1-4(2)3;;/h2*4H,1H2,2-3H3;;/q;;+1;-1'], 'amounts': ['2.1 mmol', '1.0 M', '2.1 mL'], 'appearances': []}, {'chemical_names': ['ammonium chloride'], 'identifiers': ['smiles:[Cl-].[NH4+]', 'inchi:InChI=1S/ClH.H3N/h1H;1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['(E)-3-methyl-5-(3,5-dichloro-phenyl)-pent-2-en-4-yn-1-ol'], 'identifiers': ['smiles:C/C(C#Cc1cc(Cl)cc(Cl)c1)=C\\CO', 'inchi:InChI=1S/C12H10Cl2O/c1-9(4-5-15)2-3-10-6-11(13)8-12(14)7-10/h4,6-8,15H,5H2,1H3/b9-4+'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['0.5 mL'], 'appearances': []}]",[],"['step 1:To a solution of (E)-3-methyl-5-(3,5-dichloro-phenyl)-pent-2-en-4-ynoic acid ethyl ester (130 mg, 0.46 mmol) in THF (0.5 mL) was added dropwise diisobutylaluminium hydride (1.0 M solution in toluene, 2.1 mL, 2.1 mmol) at −20° C', 'step 1 properties:Temperature:-20', 'step 2:The reaction mixture was stirred for 2 hours at −20° C., whereafter saturated ammonium chloride', 'step 2 properties:Time:7200', 'step 2 properties:Temperature:-20', 'step 3:was added', 'step 4:The mixture was treated with ethyl acetate and decalite', 'step 5:filtered', 'step 6:The filtrate was evaporated', 'step 7:to give crude (E)-3-methyl-5-(3,5-dichloro-phenyl)-pent-2-en-4-yn-1-ol in 113 mg']"
"['Cl.[F:2][C:3]1[CH:8]=[CH:7][C:6]([C@H:9]2[C:14](=[O:15])[O:13][CH2:12][CH2:11][N:10]2[CH2:16][C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)=[CH:5][CH:4]=1.[C:23](=[O:26])(O)[O-].[Na+].CCC(C)[BH-](C(C)CC)C(C)CC.[Li+].[F:42][C:43]([F:58])([F:57])[C:44]1[CH:45]=[C:46]([CH:50]=[C:51]([C:53]([F:56])([F:55])[F:54])[CH:52]=1)[C:47](Cl)=O', 'C(OCC)(=O)C', '[F:2][C:3]1[CH:4]=[CH:5][C:6]([C@H:9]2[C@@H:14]([O:15][C:23](=[O:26])[CH2:47][C:46]3[CH:50]=[C:51]([C:53]([F:55])([F:56])[F:54])[CH:52]=[C:44]([C:43]([F:42])([F:57])[F:58])[CH:45]=3)[O:13][CH2:12][CH2:11][N:10]2[CH2:16][C:17]2[CH:18]=[CH:19][CH:20]=[CH:21][CH:22]=2)=[CH:7][CH:8]=1 |f:0.1,2.3,4.5|']","['US20010041702A1', '0131', 'A stirred suspension of (S)-3-(4-fluoropheny)-4-(phenylmethyl)-2-morpholinone hydrochloride (2.30 kg, 7.15 moles) in ethyl acetate (22 L) was treated with 10% aqueous sodium bicarbonate (22 L). The resulting organic solution was sequentially washed with 10% aqueous sodium bicarbonate (11 L) and water (2×11 L), then dried overnight with 4A molecular sieves (1 L). The solution was evaporated, then flushed with tetrahydrofuran (2×3 L) in order to remove traces of ethyl acetate. The resulting free base of (S)-3-(4-fluoropheny)-4-(phenylmethyl)-2-morpholinone was dissolved in tetrahydrofuran (19 L) and chilled to −75° C. L-Selectride (lithium tri-sec-butylborohydride, 6.74 L, 1.06 M, 7.15 moles) was added to the batch while maintaining the temperature at less than −70° C. The batch was aged for 15 minutes, then 3,5-bis(trifluoromethyl)benzoyl chloride (2.57 kg, 9.29 moles) was added, maintaining the temperature at less than −70° C. The reaction was monitored by HPLC. The reaction was quenched with acetic acid (205 mL) in tetrahydrofuran (800 mL), and the batch was allowed to warm to ambient temperature overnight. The solution was vacuum concentrated and the resulting oil was diluted with hexanes (36 L). The batch was washed sequentially with water (17 L), 10% aqueous sodium bicarbonate (3×8.5 L), and water (2×8.5 L), then dried overnight using 4A molecular sieves (1 L). The batch was assayed by HPLC to contain 2.44 kg (65% yield) of (2R-cis)-3,5-bis(trifluoromethyl)-benzeneacetic acid 3-(4-fluorophenyl)-4-(phenylmethyl)-2-morpholinyl ester. This batch was combined with another batch of (2R-cis)-3,5-bis(trifluoromethyl)benzene-acetic acid 3-(4-fluorophenyl)-4-(phenylmethyl)-2-morpholinyl ester (0.59 kg assay in 7 L hexanes) that was prepared just prior to the current batch. The combined batch solutions were filtered through a 20 μm line filter then diluted with hexanes (9 L). The crude (2R-cis)-3,5-bis(trifluoro-methyl)benzeneacetic acid 3-(4-fluorophenyl)-4-(phenyl-methyl)-2-morpholinyl ester solution (3.03 kg assay, 5.74 moles) was treated with hydrochloric acid in diethyl ether (9.6 L, 1.0 M), giving a white precipitate of (2R-cis)-3,5-bis(trifluoromethyl)benzeneacetic acid 3-(4-fluorophenyl)-4-(phenylmethyl)-2-morpholinyl ester hydrochloride salt (the hydrochloride salt was formed in order to remove tri-sec-butyl borane residue (from the L-Selectride)). The solid was collected by filtration, washed with hexanes (2×8 L), then dried under nitrogen. The hydrochloride salt of the product was broken by slurrying in a mixture of toluene (36 L) and 10% aqueous sodium bicarbonate (13 L). The resulting organic solution was washed with 10% aqueous sodium bicarbonate (13 L) and water (2×18 L). The toluene solution was assayed to contain 3.00 kg of (2R-cis)-3,5-bis(trifluoromethyl)-benzeneacetic acid 3-(4-fluorophenyl)-4-(phenylmethyl)-2-morpholinyl ester (80% by area, corrected for toluene). The batch was stored over 4A molecular sieves (1 L). HPLC conditions: Column: Zorbax RX-C8, 25 cm×4.6 mm; Mobile phase: acetonitrile:0.1% aqueous phosphoric acid (75:25, v/v); Flow rate: 1.5 mL/min; Detection: Lw at 220 nm Approximate retention times: Reduced (S)-3-(4-fluoropheny)-4-(phenylmethyl)-2-morpholinone: 1.6 minutes; (S)-3-(4-fluoropheny)-4-(phenylmethyl)-2-morpholinone: 3.3 minutes; (2R-cis)-3,5-bis(trifluoromethyl)-benzeneacetic acid 3-(4-fluorophenyl)-4-(phenylmethyl)-2-morpholinyl ester: 9.2 minutes.']","[{'chemical_names': ['(S)-3-(4-fluoropheny)-4-(phenylmethyl)-2-morpholinone hydrochloride'], 'identifiers': ['smiles:Cl.O=C1OCCN(Cc2ccccc2)[C@H]1c1ccc(F)cc1', 'inchi:InChI=1S/C17H16FNO2.ClH/c18-15-8-6-14(7-9-15)16-17(20)21-11-10-19(16)12-13-4-2-1-3-5-13;/h1-9,16H,10-12H2;1H/t16-;/m0./s1'], 'amounts': ['7.15 moles', '2.30 kg'], 'appearances': []}, {'chemical_names': ['sodium bicarbonate'], 'identifiers': ['smiles:O=C([O-])O.[Na+]', 'inchi:InChI=1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1'], 'amounts': ['22 L'], 'appearances': []}, {'chemical_names': ['L-Selectride'], 'identifiers': ['smiles:CCC(C)[BH-](C(C)CC)C(C)CC.[Li+]', 'inchi:InChI=1S/C12H28B.Li/c1-7-10(4)13(11(5)8-2)12(6)9-3;/h10-13H,7-9H2,1-6H3;/q-1;+1'], 'amounts': ['7.15 moles', '1.06 M', '6.74 L'], 'appearances': []}, {'chemical_names': ['3,5-bis(trifluoromethyl)benzoyl chloride'], 'identifiers': ['smiles:O=C(Cl)c1cc(C(F)(F)F)cc(C(F)(F)F)c1', 'inchi:InChI=1S/C9H3ClF6O/c10-7(17)4-1-5(8(11,12)13)3-6(2-4)9(14,15)16/h1-3H'], 'amounts': ['9.29 moles', '2.57 kg'], 'appearances': []}]","[{'chemical_names': ['(2R-cis)-3,5-bis(trifluoromethyl)-benzeneacetic acid 3-(4-fluorophenyl)-4-(phenylmethyl)-2-morpholinyl ester'], 'identifiers': ['smiles:O=C(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)O[C@H]1OCCN(Cc2ccccc2)[C@H]1c1ccc(F)cc1', 'inchi:InChI=1S/C27H22F7NO3/c28-22-8-6-19(7-9-22)24-25(37-11-10-35(24)16-17-4-2-1-3-5-17)38-23(36)14-18-12-20(26(29,30)31)15-21(13-18)27(32,33)34/h1-9,12-13,15,24-25H,10-11,14,16H2/t24-,25+/m0/s1'], 'amounts': ['2.44 kg', '65% yield'], 'appearances': []}]","[{'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['22 L'], 'appearances': []}]",[],"['step 1:A stirred suspension of (S)-3-(4-fluoropheny)-4-(phenylmethyl)-2-morpholinone hydrochloride (2.30 kg, 7.15 moles) in ethyl acetate (22 L)', 'step 2:was treated with 10% aqueous sodium bicarbonate (22 L)', 'step 3:The resulting organic solution was sequentially washed with 10% aqueous sodium bicarbonate (11 L) and water (2×11 L)', 'step 4:dried overnight with 4A molecular sieves (1 L)', 'step 4 properties:Time:overnight', 'step 5:The solution was evaporated', 'step 6:flushed with tetrahydrofuran (2×3 L) in order', 'step 7:to remove traces of ethyl acetate', 'step 8:The resulting free base of (S)-3-(4-fluoropheny)-4-(phenylmethyl)-2-morpholinone was dissolved in tetrahydrofuran (19 L)', 'step 9:chilled to −75° C', 'step 9 properties:Temperature:-75', 'step 10:L-Selectride (lithium tri-sec-butylborohydride, 6.74 L, 1.06 M, 7.15 moles) was added to the batch', 'step 11:while maintaining the temperature at less than −70° C', 'step 11 properties:Temperature:<-70', 'step 12:The batch was aged for 15 minutes', 'step 12 properties:Time:900', 'step 13:3,5-bis(trifluoromethyl)benzoyl chloride (2.57 kg, 9.29 moles) was added', 'step 14:maintaining the temperature at less than −70° C', 'step 14 properties:Temperature:<-70', 'step 15:The reaction was quenched with acetic acid (205 mL) in tetrahydrofuran (800 mL)', 'step 16:to warm to ambient temperature overnight', 'step 16 properties:Time:overnight', 'step 16 properties:Temperature:room temperature', 'step 17:concentrated', 'step 18:the resulting oil was diluted with hexanes (36 L)', 'step 19:The batch was washed sequentially with water (17 L), 10% aqueous sodium bicarbonate (3×8.5 L), and water (2×8.5 L)', 'step 20:dried overnight', 'step 20 properties:Time:overnight']"
"['[CH2:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH2:4][CH2:3][NH:2]1.Br[CH2:12][C:13]1[O:17][N:16]=[C:15]([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)[CH:14]=1', 'CCOC(C)=O.CCCCCC', '[C:18]1([C:15]2[CH:14]=[C:13]([CH2:12][N:2]3[CH2:3][CH2:4][C:5]4[C:10](=[CH:9][CH:8]=[CH:7][CH:6]=4)[CH2:1]3)[O:17][N:16]=2)[CH:19]=[CH:20][CH:21]=[CH:22][CH:23]=1']","['US20010041714A1', '0349', ""Prepared from 1,2,3,4-tetrahydroisoquinoline and 5-(bromomethyl)-3-phenylisoxazole under typical conditions. Purification by flash chromatography on silica gel 60, eluting with 25% EtOAc in hexane produced adduct 21A (81% yield). 1H NMR(300 MHz, CDCl3, δ): 7.83-7.80 (m, 2H), 7.48-7.40 (m, 3H), 7.16-7.11 (m, 3H), 7.08-6.99 (m, 1H), 6.57 (s, 1H), 3.91 (s, 2H), 3.76 (s, 2H), 3.00-2.80 (m, 4H). 13C NMR(300 MHz, CDCl3, δ): 170.25, 162.45, 134.04, 133.75, 129.97, 129.12, 128.92, 128.72, 126.81, 126.56, 126.36, 125.78, 101.26, 85.61, 53.20, 50.75, 29.03. MS(CI, NH3) m/e 291 (base, M+H+). HRMS(CI, NH3) m/e Calc'd for (M+H+): 291.1497. Found: 291.1512.""]","[{'chemical_names': ['1,2,3,4-tetrahydroisoquinoline'], 'identifiers': ['smiles:c1ccc2c(c1)CCNC2', 'inchi:InChI=1S/C9H11N/c1-2-4-9-7-10-6-5-8(9)3-1/h1-4,10H,5-7H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['5-(bromomethyl)-3-phenylisoxazole'], 'identifiers': ['smiles:BrCc1cc(-c2ccccc2)no1', 'inchi:InChI=1S/C10H8BrNO/c11-7-9-6-10(12-13-9)8-4-2-1-3-5-8/h1-6H,7H2'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['21A', '2-(3-Phenylisoxazol-5-yl)methyl-1,2,3,4-tetrahydroisoquinoline'], 'identifiers': ['smiles:c1ccc(-c2cc(CN3CCc4ccccc4C3)on2)cc1', 'inchi:InChI=1S/C19H18N2O/c1-2-7-16(8-3-1)19-12-18(22-20-19)14-21-11-10-15-6-4-5-9-17(15)13-21/h1-9,12H,10-11,13-14H2'], 'amounts': ['81% yield'], 'appearances': []}]","[{'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['hexane'], 'identifiers': ['smiles:CCCCCC', 'inchi:InChI=1S/C6H14/c1-3-5-6-4-2/h3-6H2,1-2H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:Prepared from 1,2,3,4-tetrahydroisoquinoline and 5-(bromomethyl)-3-phenylisoxazole under typical conditions', 'step 2:Purification by flash chromatography on silica gel 60', 'step 3:eluting with 25% EtOAc in hexane produced adduct 21A (81% yield)']"
"['[CH:1]1[C:6]2[C:7]([NH:9][C:10](=[O:11])[C:5]=2[CH:4]=[N:3][CH:2]=1)=[O:8].[H-].[Na+].CI.[C:16](OCC)(=O)C', 'CN(C)C=O', '[CH3:16][N:9]1[C:7](=[O:8])[C:6]2[CH:1]=[CH:2][N:3]=[CH:4][C:5]=2[C:10]1=[O:11] |f:1.2|']","['US20010041703A1', 'A. 2-Methyl-pyrrolo[3,4-c]pyrdine-1,3-dione', '0941', 'To a stirred solution of 3,4-pyridinedicarboximide (10.0 g, 67.5 mmol) in N,N-dimethylformamide was added sodium hydride (1.55 g, 60% dispersion in mineral oil, 67.5 mmol) at room temperature. The mixture was stirred for about 30 minutes, then methyl iodide (9.58 g, 67.5 mmol) was added, and the reaction was stirred overnight. Ethyl acetate was added to the reaction mixture, and the mixture was extracted once with water, twice with brine. The organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo (azeotroping excess N,N-dimethylformamide with heptanes) to give crude product. Purification by silica gel chromatography using 0-5% methanol/dichloromethane as eluent afforded the title compound of part 11-A as an off-white solid (5 g, 46%): PB MS (M+1)+ 163; 1H NMR=250 MHz (CDCl3) δ: 9.11 (arom, s, 1H), 9.08 (arom, d, 1H), 7.75 (arom, d, 1H), 3.20 (Me, s, 3H).']","[{'chemical_names': ['3,4-pyridinedicarboximide'], 'identifiers': ['smiles:O=C1NC(=O)c2cnccc21', 'inchi:InChI=1S/C7H4N2O2/c10-6-4-1-2-8-3-5(4)7(11)9-6/h1-3H,(H,9,10,11)'], 'amounts': ['67.5 mmol', '10.0 g'], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': ['67.5 mmol', '1.55 g'], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': ['67.5 mmol', '9.58 g'], 'appearances': []}, {'chemical_names': ['Ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['title compound', '2-Methyl-pyrrolo[3,4-c]pyrdine-1,3-dione'], 'identifiers': ['smiles:CN1C(=O)c2ccncc2C1=O', 'inchi:InChI=1S/C8H6N2O2/c1-10-7(11)5-2-3-9-4-6(5)8(10)12/h2-4H,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['11-A'], 'identifiers': [], 'amounts': ['5 g', '46%'], 'appearances': ['off-white']}]","[{'chemical_names': ['N,N-dimethylformamide'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:To a stirred solution of 3,4-pyridinedicarboximide (10.0 g, 67.5 mmol) in N,N-dimethylformamide was added sodium hydride (1.55 g, 60% dispersion in mineral oil, 67.5 mmol) at room temperature', 'step 1 properties:Temperature:room temperature', 'step 2:The mixture was stirred for about 30 minutes', 'step 2 properties:Time:~1800', 'step 3:methyl iodide (9.58 g, 67.5 mmol) was added', 'step 4:the reaction was stirred overnight', 'step 4 properties:Time:overnight', 'step 5:Ethyl acetate was added to the reaction mixture', 'step 6:the mixture was extracted once with water, twice with brine', 'step 7:The organic layer was dried over anhydrous magnesium sulfate', 'step 8:filtered', 'step 9:concentrated in vacuo (azeotroping excess N,N-dimethylformamide with heptanes)', 'step 10:to give crude product', 'step 11:Purification by silica gel chromatography', 'step 12:afforded the title compound of part 11-A as an off-white solid (5 g, 46%)']"
"['CO[C:3](=[O:8])[C:4]([O:6][CH3:7])=[O:5].C[O-].[Na+].[CH3:12][S:13][C:14]1[CH:19]=[CH:18][C:17]([C:20](=[O:22])[CH3:21])=[CH:16][CH:15]=1.Cl', 'C1(C)C=CC=CC=1.CCCCCC.CCOC(C)=O', '[OH:8]/[C:3](=[CH:21]\\[C:20](=[O:22])[C:17]1[CH:18]=[CH:19][C:14]([S:13][CH3:12])=[CH:15][CH:16]=1)/[C:4]([O:6][CH3:7])=[O:5] |f:1.2|']","['US20010041726A1', '20a. Methyl (2Z)-2-hydroxy-4-(4-methylthiophenyl)oxobut-2-enoate', '1971', 'Dimethyloxalate (26 g, 180.7 mmol) was added to a stirred suspension of sodium methoxide (9.75 g, 180.7 mmol) in dry toluene (200 mL) at 0° C. The white suspension was stirred for 15 min at 0° C. A solution of 4′-(methylthio)acetophenone (15 g, 90.4 mmol) in dry toluene (150 mL) was then added dropwise over 15 min giving a yellow suspension which was stirred for 2 hours at room temperature. The thick yellow suspension was transferred to a 2 liter flask and stirred vigorously with 10% HCl (250 mL) and EtOAc (200 mL) to dissolve all the solids present. The organic layer was separated and the aqueous layer was extracted with EtOAc (100 mL). The combined organic extracts were washed with water (250 mL), dried over Na2SO4 and the solvent was evaporated under reduced pressure to give thick brown oil. The brown oil was dissolved in CIHC4 (25 mL) and hexane (125 mL) and left in a freezer at −20° C. for 16 hours to give the title compound (18 g, 79%) as orange color solid. mp 81° C. 1H-NMR (300 MHz, CDCl3) 3 7.83 (d, J=8.6 Hz, 2H), 7.23 (d, J=8.6 Hz, 2H), 6.97 (s, 1H), 3.89 (s, 3H), 2.47 (s, 3H); 13C-NMR (75 MHz, CDCl3); mass spectrum (API-TIS) m/z 253 (MH+)']","[{'chemical_names': ['Dimethyloxalate'], 'identifiers': ['smiles:COC(=O)C(=O)OC', 'inchi:InChI=1S/C4H6O4/c1-7-3(5)4(6)8-2/h1-2H3'], 'amounts': ['180.7 mmol', '26 g'], 'appearances': []}, {'chemical_names': ['sodium methoxide'], 'identifiers': ['smiles:C[O-].[Na+]', 'inchi:InChI=1S/CH3O.Na/c1-2;/h1H3;/q-1;+1'], 'amounts': ['180.7 mmol', '9.75 g'], 'appearances': []}, {'chemical_names': ['4′-(methylthio)acetophenone'], 'identifiers': ['smiles:CSc1ccc(C(C)=O)cc1', 'inchi:InChI=1S/C9H10OS/c1-7(10)8-3-5-9(11-2)6-4-8/h3-6H,1-2H3'], 'amounts': ['90.4 mmol', '15 g'], 'appearances': []}, {'chemical_names': ['HCl'], 'identifiers': ['smiles:Cl', 'inchi:InChI=1S/ClH/h1H'], 'amounts': ['250 mL'], 'appearances': []}]","[{'chemical_names': ['title compound', 'Methyl (2Z)-2-hydroxy-4-(4-methylthiophenyl)oxobut-2-enoate'], 'identifiers': ['smiles:COC(=O)/C(O)=C/C(=O)c1ccc(SC)cc1', 'inchi:InChI=1S/C12H12O4S/c1-16-12(15)11(14)7-10(13)8-3-5-9(17-2)6-4-8/h3-7,14H,1-2H3/b11-7-'], 'amounts': ['18 g', '79%', '78.9'], 'appearances': []}]","[{'chemical_names': ['toluene'], 'identifiers': ['smiles:Cc1ccccc1', 'inchi:InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3'], 'amounts': ['200 mL'], 'appearances': []}, {'chemical_names': ['toluene'], 'identifiers': ['smiles:Cc1ccccc1', 'inchi:InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3'], 'amounts': ['150 mL'], 'appearances': []}, {'chemical_names': ['hexane'], 'identifiers': ['smiles:CCCCCC', 'inchi:InChI=1S/C6H14/c1-3-5-6-4-2/h3-6H2,1-2H3'], 'amounts': ['125 mL'], 'appearances': []}, {'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['200 mL'], 'appearances': []}]",[],"['step 1:Dimethyloxalate (26 g, 180.7 mmol) was added to a stirred suspension of sodium methoxide (9.75 g, 180.7 mmol) in dry toluene (200 mL) at 0° C', 'step 1 properties:Temperature:0', 'step 2:The white suspension was stirred for 15 min at 0° C', 'step 2 properties:Time:900', 'step 2 properties:Temperature:0', 'step 3:A solution of 4′-(methylthio)acetophenone (15 g, 90.4 mmol) in dry toluene (150 mL) was then added dropwise over 15 min', 'step 3 properties:Time:900', 'step 4:giving a yellow suspension which', 'step 5:was stirred for 2 hours at room temperature', 'step 5 properties:Time:7200', 'step 5 properties:Temperature:room temperature', 'step 6:The thick yellow suspension was transferred to a 2 liter flask', 'step 7:stirred vigorously with 10% HCl (250 mL) and EtOAc (200 mL)', 'step 8:to dissolve all the solids present', 'step 9:The organic layer was separated', 'step 10:the aqueous layer was extracted with EtOAc (100 mL)', 'step 11:The combined organic extracts were washed with water (250 mL)', 'step 12:dried over Na2SO4', 'step 13:the solvent was evaporated under reduced pressure', 'step 13 properties:Pressure:reduced pressure', 'step 14:to give thick brown oil', 'step 15:The brown oil was dissolved in CIHC4 (25 mL) and hexane (125 mL)', 'step 16:left in a freezer at −20° C. for 16 hours', 'step 16 properties:Time:57600', 'step 16 properties:Temperature:-20', 'step 17:to give the title compound (18 g, 79%) as orange color solid']"
"['[CH3:1][O:2][C:3](=[O:16])[C@H:4]([CH2:9][CH:10]1[CH2:15][CH2:14][CH2:13][CH2:12][CH2:11]1)[CH2:5][C:6]([OH:8])=O.C(Cl)CCl.ON1C2C=CC=CC=2N=N1.[NH:31]1[CH2:36][CH2:35][O:34][CH2:33][CH2:32]1', 'CN(C=O)C.CCOC(C)=O', '[CH3:1][O:2][C:3](=[O:16])[C@H:4]([CH2:9][CH:10]1[CH2:15][CH2:14][CH2:13][CH2:12][CH2:11]1)[CH2:5][C:6]([N:31]1[CH2:36][CH2:35][O:34][CH2:33][CH2:32]1)=[O:8]']","['US20010041700A1', '0702', '(R)-2-(Cyclohexylmethyl) succinic acid 1-methyl ester (1.00 g, 4.38 mmol) was dissolved in 10 mL of DMF and cooled to 0° C. with an ice-water bath. EDC (1.12 g, 5.69 mmol) then 1-hydroxybenzotriazole (0.77 g, 5.69 mmol) were added and stirring continued, under argon, for 25 min. Morpholine (0.76 mL, 8.76 mmol) was added and stirring was continued overnight (16 h). The solution was diluted with 200 mL of EtOAc and washed with a 1.0 M solution of HCl (3×100 mL), a saturated solution of NaHCO3 (3×100 mL), water (100 mL), then with brine (100 mL). The organic layer was dried over MgSO4, filtered and concentrated by rotary evaporation to give (R)-2-Cyclohexylmethyl-4-morpholin-4-yl-4-oxo-butyric acid 1-methyl ester (1.26 g, 99%) as a white solid. The product was used in the following step without purification.']","[{'chemical_names': ['(R)-2-(Cyclohexylmethyl) succinic acid 1-methyl ester'], 'identifiers': ['smiles:COC(=O)[C@@H](CC(=O)O)CC1CCCCC1', 'inchi:InChI=1S/C12H20O4/c1-16-12(15)10(8-11(13)14)7-9-5-3-2-4-6-9/h9-10H,2-8H2,1H3,(H,13,14)/t10-/m1/s1'], 'amounts': ['4.38 mmol', '1.00 g'], 'appearances': []}, {'chemical_names': ['EDC'], 'identifiers': ['smiles:ClCCCl', 'inchi:InChI=1S/C2H4Cl2/c3-1-2-4/h1-2H2'], 'amounts': ['5.69 mmol', '1.12 g'], 'appearances': []}, {'chemical_names': ['1-hydroxybenzotriazole'], 'identifiers': ['smiles:On1nnc2ccccc21', 'inchi:InChI=1S/C6H5N3O/c10-9-6-4-2-1-3-5(6)7-8-9/h1-4,10H'], 'amounts': ['5.69 mmol', '0.77 g'], 'appearances': []}, {'chemical_names': ['Morpholine'], 'identifiers': ['smiles:C1COCCN1', 'inchi:InChI=1S/C4H9NO/c1-3-6-4-2-5-1/h5H,1-4H2'], 'amounts': ['8.76 mmol', '0.76 mL'], 'appearances': []}]","[{'chemical_names': ['(R)-2-Cyclohexylmethyl-4-morpholin-4-yl-4-oxo-butyric acid 1-methyl ester'], 'identifiers': ['smiles:COC(=O)[C@@H](CC(=O)N1CCOCC1)CC1CCCCC1', 'inchi:InChI=1S/C16H27NO4/c1-20-16(19)14(11-13-5-3-2-4-6-13)12-15(18)17-7-9-21-10-8-17/h13-14H,2-12H2,1H3/t14-/m1/s1'], 'amounts': ['1.26 g', '99%', '96.7'], 'appearances': ['white']}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['10 mL'], 'appearances': []}, {'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['200 mL'], 'appearances': []}]",[],"['step 1:(R)-2-(Cyclohexylmethyl) succinic acid 1-methyl ester (1.00 g, 4.38 mmol) was dissolved in 10 mL of DMF', 'step 2:cooled to 0° C. with an ice-water bath', 'step 2 properties:Temperature:0', 'step 3:EDC (1.12 g, 5.69 mmol) then 1-hydroxybenzotriazole (0.77 g, 5.69 mmol) were added', 'step 4:stirring continued, under argon, for 25 min', 'step 4 properties:Time:1500', 'step 5:Morpholine (0.76 mL, 8.76 mmol) was added', 'step 6:stirring', 'step 7:was continued overnight', 'step 7 properties:Time:overnight', 'step 8:(16 h)', 'step 8 properties:Time:57600', 'step 9:The solution was diluted with 200 mL of EtOAc', 'step 10:washed with a 1.0 M solution of HCl (3×100 mL)', 'step 11:The organic layer was dried over MgSO4', 'step 12:filtered', 'step 13:concentrated by rotary evaporation', 'step 14:to give (R)-2-Cyclohexylmethyl-4-morpholin-4-yl-4-oxo-butyric acid 1-methyl ester (1.26 g, 99%) as a white solid']"
"['O.NN.[CH3:4][C:5]1[C@@H:22]([O:23]C(C)=O)[CH2:21][C@:17]2([OH:27])[C:18]([CH3:20])([CH3:19])[C:6]=1[C@@H:7]([O:45]C(C)=O)[C:8]([C@@:10]1([CH3:44])[C@H:15]([C@@H:16]2[O:28][C:29]([C:31]2[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=2)=[O:30])[C@:14]2([O:39][C:40]([CH3:42])=[O:41])[CH2:37][O:38][C@@H:13]2[CH2:12][C@@H:11]1[OH:43])=[O:9].C(OCC)(=O)C', 'C(O)C', '[CH3:4][C:5]1[C@@H:22]([OH:23])[CH2:21][C@:17]2([OH:27])[C:18]([CH3:19])([CH3:20])[C:6]=1[C@@H:7]([OH:45])[C:8]([C@@:10]1([CH3:44])[C@H:15]([C@@H:16]2[O:28][C:29]([C:31]2[CH:32]=[CH:33][CH:34]=[CH:35][CH:36]=2)=[O:30])[C@:14]2([O:39][C:40]([CH3:42])=[O:41])[CH2:37][O:38][C@@H:13]2[CH2:12][C@@H:11]1[OH:43])=[O:9] |f:0.1|']","['US20010041803A1', '10-Deacetyl Baccatin III (10-DAB III)', '0094', 'Hydrazine monohydrate was added to a solution of 13-Acetyl baccatin III (1000 mg, 2.56 mmol) in 95% ethanol and the mixture stirred at room temperature for 8 hours. Excess ethyl acetate (200 ml) added and the mixture was extracted with water (150 ml), brine (150 ml), and Water (150 ml). The organic layer was dried (anhydrous MgSO4) and concentrated to dryness. The final compound was purified by flash column ethyl acetate/hexane 4:1 to yield 860.5 mg, 85%. 1H NMR (deuterated acetone) d 8.12 (m, ortho —H), 8.01 (m, para-H), 7.56 (m, meta-H), 5.65 (d, J=7.04 Hz, C-2), 5.27 (s, H-10), 4.96 (dd, J=2.09, 9.58 Hz, C-13), 4.55 (d, J=4.63 Hz, H-5), 4.23 (m, C-7), 4.13 (d, J=7.38 Hz, H-14α), 4.04 (d, J=7.04 Hz, H-14β), 4.16 (s, OH), 2.83 (s, OH), 2.49 (m, 2H, C-14), 2.33 (m, 1H, H-6α), 1.83 (m, 1H, H-6β), 2.08 (s, 3H, C-4-OCOCH3), 2.26 (s, OH), 2.05 (s, H-18), 1.71 (s, H-19), 1.10 (s, 3H, H-16), 1.10 (s, H-17); 13C NMR (deuterated acetone) d, 10.37 (C-19), 15.78 (C-18), 20.69 (C-17), 22.79 (C-16), 27.3 (C-4), 37.79 (C-14), 40.95 (C-15), 43.76 (C-8), 48.14 (C-3), 68.02 (C-13), 72.66 (C-10), 75.88 (C-2), 76.15 (C-20), 76.93 (C-9), 78.70 (C-1), 80.53 (C-4), 85.18 (C-5), 129.46 (meta C), 130.86 (ortho C), 134.04 (para C), 1135.76 (C-11), 143 (C-12), 170.87 (C-10), 206 (C-9)']","[{'chemical_names': ['Hydrazine monohydrate'], 'identifiers': ['smiles:NN.O', 'inchi:InChI=1S/H4N2.H2O/c1-2;/h1-2H2;1H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['13-Acetyl baccatin III'], 'identifiers': ['smiles:CC(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@H]3[C@](C)(C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](O)C[C@H]1OC[C@]13OC(C)=O', 'inchi:InChI=1S/C33H40O12/c1-16-21(42-17(2)34)14-33(40)28(44-29(39)20-11-9-8-10-12-20)26-31(7,22(37)13-23-32(26,15-41-23)45-19(4)36)27(38)25(43-18(3)35)24(16)30(33,5)6/h8-12,21-23,25-26,28,37,40H,13-15H2,1-7H3/t21-,22-,23+,25+,26-,28-,31+,32-,33+/m0/s1'], 'amounts': ['2.56 mmol', '1000 mg'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['200 ml'], 'appearances': []}]","[{'chemical_names': ['10-Deacetyl Baccatin III'], 'identifiers': ['smiles:CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](O)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C', 'inchi:InChI=1S/C29H36O10/c1-14-17(31)12-29(36)24(38-25(35)16-9-7-6-8-10-16)22-27(5,23(34)21(33)20(14)26(29,3)4)18(32)11-19-28(22,13-37-19)39-15(2)30/h6-10,17-19,21-22,24,31-33,36H,11-13H2,1-5H3/t17-,18-,19+,21+,22-,24-,27+,28-,29+/m0/s1'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['ethanol'], 'identifiers': ['smiles:CCO', 'inchi:InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:Hydrazine monohydrate was added to a solution of 13-Acetyl baccatin III (1000 mg, 2.56 mmol) in 95% ethanol', 'step 2:the mixture stirred at room temperature for 8 hours', 'step 2 properties:Time:28800', 'step 2 properties:Temperature:room temperature', 'step 3:Excess ethyl acetate (200 ml) added', 'step 4:the mixture was extracted with water (150 ml), brine (150 ml), and Water (150 ml)', 'step 5:The organic layer was dried (anhydrous MgSO4)', 'step 6:concentrated to dryness', 'step 7:The final compound was purified by flash column ethyl acetate/hexane 4:1', 'step 8:to yield 860.5 mg, 85%']"
"['[CH3:1][NH:2][C@@H:3]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[C@H:6]([C:13]2[CH:14]=[CH:15][C:16]([Cl:20])=[C:17]([Cl:19])[CH:18]=2)[CH2:5][CH2:4]1.C([O-])(=O)C(C1C=CC=CC=1)O.[OH-].[Na+]', 'C(OCC)(=O)C', '[CH3:1][NH:2][C@@H:3]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[C@H:6]([C:13]2[CH:14]=[CH:15][C:16]([Cl:20])=[C:17]([Cl:19])[CH:18]=2)[CH2:5][CH2:4]1 |f:0.1,2.3|']","['US20010041815A1', '0068', 'Sertraline base for use in the processes of the present invention may be produced by dissolving sertraline mandelate in ethyl acetate followed by neutralization of the sertraline mandelate with aqueous sodium hydroxide. The organic phase is separated from the aqueous phase and dried using magnesium sulfate. The solvent is removed under reduced pressure to produce sertraline base as an oil. Methods for making sertraline base are set forth in U.S. Pat. Nos. 4,536,518 and 5,248,699, the contents of which are incorporated herein by reference.']","[{'chemical_names': ['sertraline mandelate'], 'identifiers': ['smiles:CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21.O=C([O-])C(O)c1ccccc1', 'inchi:InChI=1S/C17H17Cl2N.C8H8O3/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11;9-7(8(10)11)6-4-2-1-3-5-6/h2-6,8,10,12,17,20H,7,9H2,1H3;1-5,7,9H,(H,10,11)/p-1/t12-,17-;/m0./s1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sertraline mandelate'], 'identifiers': ['smiles:CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21.O=C([O-])C(O)c1ccccc1', 'inchi:InChI=1S/C17H17Cl2N.C8H8O3/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11;9-7(8(10)11)6-4-2-1-3-5-6/h2-6,8,10,12,17,20H,7,9H2,1H3;1-5,7,9H,(H,10,11)/p-1/t12-,17-;/m0./s1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydroxide'], 'identifiers': ['smiles:[Na+].[OH-]', 'inchi:InChI=1S/Na.H2O/h;1H2/q+1;/p-1'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['sertraline'], 'identifiers': ['smiles:CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21', 'inchi:InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:by dissolving sertraline mandelate in ethyl acetate', 'step 2:The organic phase is separated from the aqueous phase', 'step 3:dried', 'step 4:The solvent is removed under reduced pressure', 'step 4 properties:Pressure:reduced pressure', 'step 5:to produce sertraline base as an oil']"
"['[OH-].[Na+].[CH2:3]([O:5][C:6](=[O:13])[CH:7]1[CH2:12][CH2:11][CH2:10][NH:9][CH2:8]1)[CH3:4].[CH3:14][C:15]([O:18][C:19](O[C:19]([O:18][C:15]([CH3:17])([CH3:16])[CH3:14])=[O:20])=[O:20])([CH3:17])[CH3:16].CCOC(C)=O', 'O1CCCC1.O', '[CH2:3]([O:5][C:6]([CH:7]1[CH2:12][CH2:11][CH2:10][N:9]([C:19]([O:18][C:15]([CH3:17])([CH3:16])[CH3:14])=[O:20])[CH2:8]1)=[O:13])[CH3:4] |f:0.1|']","['US20010041720A1', '0098', 'A one-necked round-bottom flask (1l) equipped with a magnetic stirrer and addition funnel was charged with NaOH-pellets (15,6 g), tetrahydrofuran (400 ml) and ethylnipecotate (50 ml, 324 mmol). To the stirred mixture at room temperature was added dropwise a solution of Boc2O (84,9 g, 389 mmol) dissolved in tetrahydrofuran (150 ml) (1 hour, precipitation of white solid, NaOH-pellets dissolved, exoterm). The mixture was stirred overnight at room temperature. The mixture was added to EtOAc (500 ml) and H2O (2000 ml), and the aqueous layer was re-extracted with EtOAc (2×500 ml) and the combined organic layers were washed with brine (100 ml), dried over MgSO4, filtered and concentrated in vacuo to afford piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester (82,5 g) as a thin yellow oil.']","[{'chemical_names': ['( 1l )'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['NaOH'], 'identifiers': ['smiles:[Na+].[OH-]', 'inchi:InChI=1S/Na.H2O/h;1H2/q+1;/p-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['ethylnipecotate'], 'identifiers': ['smiles:CCOC(=O)C1CCCNC1', 'inchi:InChI=1S/C8H15NO2/c1-2-11-8(10)7-4-3-5-9-6-7/h7,9H,2-6H2,1H3'], 'amounts': ['324 mmol', '50 ml'], 'appearances': []}, {'chemical_names': ['Boc2O'], 'identifiers': ['smiles:CC(C)(C)OC(=O)OC(=O)OC(C)(C)C', 'inchi:InChI=1S/C10H18O5/c1-9(2,3)14-7(11)13-8(12)15-10(4,5)6/h1-6H3'], 'amounts': ['389 mmol', '84,9 g'], 'appearances': []}, {'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['500 ml'], 'appearances': []}]","[{'chemical_names': ['piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester'], 'identifiers': ['smiles:CCOC(=O)C1CCCN(C(=O)OC(C)(C)C)C1', 'inchi:InChI=1S/C13H23NO4/c1-5-17-11(15)10-7-6-8-14(9-10)12(16)18-13(2,3)4/h10H,5-9H2,1-4H3'], 'amounts': ['82,5 g', '99.0'], 'appearances': ['thin yellow']}]","[{'chemical_names': ['tetrahydrofuran'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['150 ml'], 'appearances': ['white']}, {'chemical_names': ['tetrahydrofuran'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['400 ml'], 'appearances': []}, {'chemical_names': ['H2O'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['2000 ml'], 'appearances': []}]",[],"['step 1:A one-necked round-bottom flask (1l) equipped with a magnetic stirrer and addition funnel', 'step 2:was charged with NaOH-pellets (15,6 g), tetrahydrofuran (400 ml) and ethylnipecotate (50 ml, 324 mmol)', 'step 3:To the stirred mixture at room temperature was added dropwise a solution of Boc2O (84,9 g, 389 mmol)', 'step 3 properties:Temperature:room temperature', 'step 4:dissolved in tetrahydrofuran (150 ml) (1 hour, precipitation of white solid, NaOH-pellets dissolved, exoterm)', 'step 4 properties:Time:3600', 'step 5:The mixture was stirred overnight at room temperature', 'step 5 properties:Time:overnight', 'step 5 properties:Temperature:room temperature', 'step 6:The mixture was added to EtOAc (500 ml) and H2O (2000 ml)', 'step 7:the aqueous layer was re-extracted with EtOAc (2×500 ml)', 'step 8:the combined organic layers were washed with brine (100 ml)', 'step 9:dried over MgSO4', 'step 10:filtered', 'step 11:concentrated in vacuo', 'step 12:to afford piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester (82,5 g) as a thin yellow oil']"
"['Cl.Cl.[CH3:3][NH:4][N:5]([CH3:7])[CH3:6].C(N(C(C)C)CC)(C)C.[C:17]([O:21][C:22]([N:24]1[CH2:29][CH2:28][CH2:27][C@:26]([CH2:33][C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)([C:30](O)=[O:31])[CH2:25]1)=[O:23])([CH3:20])([CH3:19])[CH3:18].C(OC(N1CCC[C@@](CC2C=CC=CC=2)(C(O)=O)C1)=O)(C)(C)C', 'O1CCCC1.CCOC(C)=O.CCCCCCC', '[C:17]([O:21][C:22]([N:24]1[CH2:29][CH2:28][CH2:27][C@@:26]([CH2:33][C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)([C:30]([N:4]([CH3:3])[N:5]([CH3:7])[CH3:6])=[O:31])[CH2:25]1)=[O:23])([CH3:20])([CH3:19])[CH3:18] |f:0.1.2|']","['US20010041720A1', '0115', 'Trimethylhydrazine dihydrochloride (15,3 g, 104 mmol) was suspended in tetrahydrofuran (250 ml) in a one-neck round-bottom flask (1l) equipped with a large magnetic stirrer, and an addition funnel/nitrogen bubbler. The flask was then placed in a water-bath (temp: 10-20° C.), bromo-tris-pyrrolydino-phosphonium-hexafluorophosphate (40,4 g, 86,7 mmol) was added, and under vigorous stirring dropwise addition of diisopropylethylamine (59 ml, 347 mmol). The mixture (with heavy precipitation) was stirred for 5 min., and a solution of the product from step d which is either (3R)-3-benzylpiperidine-1,3-dicarboxylic acid 1-tert-butyl ester or (3S)-3-benzylpiperidine-1,3-dicarboxylic acid 1-tert-butyl ester (27,7 g, 86,7 mmol) in tetrahydrofuran (250 ml) was added slowly over 1,5 hour. The mixture was stirred overnight at room temperature. The reaction was diluted with EtOAc (1000 ml), washed with H2O (500 ml), aqueous NaHSO4, (200 ml, 10%), aqueous NaHCO3 (200 ml, saturated), brine (200 ml), dried over MgSO4, filtered and concentrated in vacuo to afford a thin orange oil. The mixture was dissolved in EtOAc (300 ml), added to SiO2 (150 g) and concentrated in vacuo to a dry powder which was applied onto a filter packed with SiO2 (150 g), washed with heptan (1l) and the desired compound was liberated with EtOAc (2,5l). After concentration in vacuo, the product which is either (3R)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)-piperidine-1-carboxylic acid tert-butyl ester or (3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)-piperidine-1-carboxylic acid tert-butyl ester (49 g) as an orange oil was obtained.']","[{'chemical_names': ['Trimethylhydrazine dihydrochloride'], 'identifiers': ['smiles:CNN(C)C.Cl.Cl', 'inchi:InChI=1S/C3H10N2.2ClH/c1-4-5(2)3;;/h4H,1-3H3;2*1H'], 'amounts': ['104 mmol', '15,3 g'], 'appearances': []}, {'chemical_names': ['diisopropylethylamine'], 'identifiers': ['smiles:CCN(C(C)C)C(C)C', 'inchi:InChI=1S/C8H19N/c1-6-9(7(2)3)8(4)5/h7-8H,6H2,1-5H3'], 'amounts': ['347 mmol', '59 ml'], 'appearances': []}, {'chemical_names': ['(3R)-3-benzylpiperidine-1,3-dicarboxylic acid 1-tert-butyl ester'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCC[C@](Cc2ccccc2)(C(=O)O)C1', 'inchi:InChI=1S/C18H25NO4/c1-17(2,3)23-16(22)19-11-7-10-18(13-19,15(20)21)12-14-8-5-4-6-9-14/h4-6,8-9H,7,10-13H2,1-3H3,(H,20,21)/t18-/m1/s1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['(3S)-3-benzylpiperidine-1,3-dicarboxylic acid 1-tert-butyl ester'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCC[C@@](Cc2ccccc2)(C(=O)O)C1', 'inchi:InChI=1S/C18H25NO4/c1-17(2,3)23-16(22)19-11-7-10-18(13-19,15(20)21)12-14-8-5-4-6-9-14/h4-6,8-9H,7,10-13H2,1-3H3,(H,20,21)/t18-/m0/s1'], 'amounts': ['86,7 mmol', '27,7 g'], 'appearances': []}, {'chemical_names': ['SiO2'], 'identifiers': [], 'amounts': ['150 g'], 'appearances': []}]","[{'chemical_names': ['(3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)-piperidine-1-carboxylic acid tert-butyl ester'], 'identifiers': ['smiles:CN(C)N(C)C(=O)[C@]1(Cc2ccccc2)CCCN(C(=O)OC(C)(C)C)C1', 'inchi:InChI=1S/C21H33N3O3/c1-20(2,3)27-19(26)24-14-10-13-21(16-24,18(25)23(6)22(4)5)15-17-11-8-7-9-12-17/h7-9,11-12H,10,13-16H2,1-6H3/t21-/m0/s1'], 'amounts': ['49 g'], 'appearances': ['orange']}]","[{'chemical_names': ['tetrahydrofuran'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['250 ml'], 'appearances': []}, {'chemical_names': ['tetrahydrofuran'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['250 ml'], 'appearances': []}, {'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['1000 ml'], 'appearances': []}, {'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['300 ml'], 'appearances': []}, {'chemical_names': ['( 1l )', 'heptan'], 'identifiers': ['smiles:CCCCCCC', 'inchi:InChI=1S/C7H16/c1-3-5-7-6-4-2/h3-7H2,1-2H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:Trimethylhydrazine dihydrochloride (15,3 g, 104 mmol) was suspended in tetrahydrofuran (250 ml) in a one-neck round-bottom flask', 'step 2:(1l) equipped with a large magnetic stirrer, and an addition funnel/nitrogen bubbler', 'step 3:The flask was then placed in a water-bath', 'step 4:(temp: 10-20° C.), bromo-tris-pyrrolydino-phosphonium-hexafluorophosphate (40,4 g, 86,7 mmol) was added', 'step 4 properties:Temperature:10 to 20', 'step 5:under vigorous stirring dropwise', 'step 6:addition of diisopropylethylamine (59 ml, 347 mmol)', 'step 7:The mixture (with heavy precipitation)', 'step 8:was stirred for 5 min.', 'step 8 properties:Time:300', 'step 9:was added slowly over 1,5 hour', 'step 9 properties:Time:5400', 'step 10:The mixture was stirred overnight at room temperature', 'step 10 properties:Time:overnight', 'step 10 properties:Temperature:room temperature', 'step 11:The reaction was diluted with EtOAc (1000 ml)', 'step 12:washed with H2O (500 ml), aqueous NaHSO4, (200 ml, 10%), aqueous NaHCO3 (200 ml, saturated), brine (200 ml)', 'step 13:dried over MgSO4', 'step 14:filtered', 'step 15:concentrated in vacuo', 'step 16:to afford a thin orange oil', 'step 17:The mixture was dissolved in EtOAc (300 ml)', 'step 18:added to SiO2 (150 g)', 'step 19:concentrated in vacuo to a dry powder which', 'step 20:washed with heptan (1l)', 'step 21:After concentration in vacuo', 'step 22:(3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)-piperidine-1-carboxylic acid tert-butyl ester (49 g) as an orange oil was obtained']"
"['Cl.Cl.[CH3:3][NH:4][N:5]([CH3:7])[CH3:6].C(N(C(C)C)CC)(C)C.[C:17]([O:21][C:22]([N:24]1[CH2:29][CH2:28][CH2:27][C@:26]([CH2:33][C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)([C:30](O)=[O:31])[CH2:25]1)=[O:23])([CH3:20])([CH3:19])[CH3:18].C(OC(N1CCC[C@@](CC2C=CC=CC=2)(C(O)=O)C1)=O)(C)(C)C', 'O1CCCC1.CCOC(C)=O.CCCCCCC', '[C:17]([O:21][C:22]([N:24]1[CH2:29][CH2:28][CH2:27][C@@:26]([CH2:33][C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)([C:30]([N:4]([CH3:3])[N:5]([CH3:7])[CH3:6])=[O:31])[CH2:25]1)=[O:23])([CH3:20])([CH3:19])[CH3:18] |f:0.1.2|']","['US20010041720A1', '0115', 'Trimethylhydrazine dihydrochloride (15,3 g, 104 mmol) was suspended in tetrahydrofuran (250 ml) in a one-neck round-bottom flask (1l) equipped with a large magnetic stirrer, and an addition funnel/nitrogen bubbler. The flask was then placed in a water-bath (temp: 10-20° C.), bromo-tris-pyrrolydino-phosphonium-hexafluorophosphate (40,4 g, 86,7 mmol) was added, and under vigorous stirring dropwise addition of diisopropylethylamine (59 ml, 347 mmol). The mixture (with heavy precipitation) was stirred for 5 min., and a solution of the product from step d which is either (3R)-3-benzylpiperidine-1,3-dicarboxylic acid 1-tert-butyl ester or (3S)-3-benzylpiperidine-1,3-dicarboxylic acid 1-tert-butyl ester (27,7 g, 86,7 mmol) in tetrahydrofuran (250 ml) was added slowly over 1,5 hour. The mixture was stirred overnight at room temperature. The reaction was diluted with EtOAc (1000 ml), washed with H2O (500 ml), aqueous NaHSO4, (200 ml, 10%), aqueous NaHCO3 (200 ml, saturated), brine (200 ml), dried over MgSO4, filtered and concentrated in vacuo to afford a thin orange oil. The mixture was dissolved in EtOAc (300 ml), added to SiO2 (150 g) and concentrated in vacuo to a dry powder which was applied onto a filter packed with SiO2 (150 g), washed with heptan (1l) and the desired compound was liberated with EtOAc (2,5l). After concentration in vacuo, the product which is either (3R)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)-piperidine-1-carboxylic acid tert-butyl ester or (3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)-piperidine-1-carboxylic acid tert-butyl ester (49 g) as an orange oil was obtained.']","[{'chemical_names': ['Trimethylhydrazine dihydrochloride'], 'identifiers': ['smiles:CNN(C)C.Cl.Cl', 'inchi:InChI=1S/C3H10N2.2ClH/c1-4-5(2)3;;/h4H,1-3H3;2*1H'], 'amounts': ['104 mmol', '15,3 g'], 'appearances': []}, {'chemical_names': ['diisopropylethylamine'], 'identifiers': ['smiles:CCN(C(C)C)C(C)C', 'inchi:InChI=1S/C8H19N/c1-6-9(7(2)3)8(4)5/h7-8H,6H2,1-5H3'], 'amounts': ['347 mmol', '59 ml'], 'appearances': []}, {'chemical_names': ['(3R)-3-benzylpiperidine-1,3-dicarboxylic acid 1-tert-butyl ester'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCC[C@](Cc2ccccc2)(C(=O)O)C1', 'inchi:InChI=1S/C18H25NO4/c1-17(2,3)23-16(22)19-11-7-10-18(13-19,15(20)21)12-14-8-5-4-6-9-14/h4-6,8-9H,7,10-13H2,1-3H3,(H,20,21)/t18-/m1/s1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['(3S)-3-benzylpiperidine-1,3-dicarboxylic acid 1-tert-butyl ester'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CCC[C@@](Cc2ccccc2)(C(=O)O)C1', 'inchi:InChI=1S/C18H25NO4/c1-17(2,3)23-16(22)19-11-7-10-18(13-19,15(20)21)12-14-8-5-4-6-9-14/h4-6,8-9H,7,10-13H2,1-3H3,(H,20,21)/t18-/m0/s1'], 'amounts': ['86,7 mmol', '27,7 g'], 'appearances': []}, {'chemical_names': ['SiO2'], 'identifiers': [], 'amounts': ['150 g'], 'appearances': []}]","[{'chemical_names': ['(3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)-piperidine-1-carboxylic acid tert-butyl ester'], 'identifiers': ['smiles:CN(C)N(C)C(=O)[C@]1(Cc2ccccc2)CCCN(C(=O)OC(C)(C)C)C1', 'inchi:InChI=1S/C21H33N3O3/c1-20(2,3)27-19(26)24-14-10-13-21(16-24,18(25)23(6)22(4)5)15-17-11-8-7-9-12-17/h7-9,11-12H,10,13-16H2,1-6H3/t21-/m0/s1'], 'amounts': ['49 g'], 'appearances': ['orange']}]","[{'chemical_names': ['tetrahydrofuran'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['250 ml'], 'appearances': []}, {'chemical_names': ['tetrahydrofuran'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['250 ml'], 'appearances': []}, {'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['1000 ml'], 'appearances': []}, {'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['300 ml'], 'appearances': []}, {'chemical_names': ['( 1l )', 'heptan'], 'identifiers': ['smiles:CCCCCCC', 'inchi:InChI=1S/C7H16/c1-3-5-7-6-4-2/h3-7H2,1-2H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:Trimethylhydrazine dihydrochloride (15,3 g, 104 mmol) was suspended in tetrahydrofuran (250 ml) in a one-neck round-bottom flask', 'step 2:(1l) equipped with a large magnetic stirrer, and an addition funnel/nitrogen bubbler', 'step 3:The flask was then placed in a water-bath', 'step 4:(temp: 10-20° C.), bromo-tris-pyrrolydino-phosphonium-hexafluorophosphate (40,4 g, 86,7 mmol) was added', 'step 4 properties:Temperature:10 to 20', 'step 5:under vigorous stirring dropwise', 'step 6:addition of diisopropylethylamine (59 ml, 347 mmol)', 'step 7:The mixture (with heavy precipitation)', 'step 8:was stirred for 5 min.', 'step 8 properties:Time:300', 'step 9:was added slowly over 1,5 hour', 'step 9 properties:Time:5400', 'step 10:The mixture was stirred overnight at room temperature', 'step 10 properties:Time:overnight', 'step 10 properties:Temperature:room temperature', 'step 11:The reaction was diluted with EtOAc (1000 ml)', 'step 12:washed with H2O (500 ml), aqueous NaHSO4, (200 ml, 10%), aqueous NaHCO3 (200 ml, saturated), brine (200 ml)', 'step 13:dried over MgSO4', 'step 14:filtered', 'step 15:concentrated in vacuo', 'step 16:to afford a thin orange oil', 'step 17:The mixture was dissolved in EtOAc (300 ml)', 'step 18:added to SiO2 (150 g)', 'step 19:concentrated in vacuo to a dry powder which', 'step 20:washed with heptan (1l)', 'step 21:After concentration in vacuo', 'step 22:(3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)-piperidine-1-carboxylic acid tert-butyl ester (49 g) as an orange oil was obtained']"
"['[NH:1]([C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[C:2]([C:5]([OH:7])=O)([CH3:4])[CH3:3].ON1C2N=CC=CC=2N=N1.Cl.C(N=C=NCCCN(C)C)C.C(N(C(C)C)CC)(C)C.[CH3:46][N:47]([CH3:79])[N:48]([CH3:78])[C:49]([C@@:51]1([CH2:71][C:72]2[CH:77]=[CH:76][CH:75]=[CH:74][CH:73]=2)[CH2:56][CH2:55][CH2:54][N:53]([C:57](=[O:70])[C@H:58]([NH2:69])[CH2:59][C:60]2[C:68]3[C:63](=[CH:64][CH:65]=[CH:66][CH:67]=3)[NH:62][CH:61]=2)[CH2:52]1)=[O:50].CN(C)N(C)C([C@]1(CC2C=CC=CC=2)CCCN(C(=O)[C@H](N)CC2C3C(=CC=CC=3)NC=2)C1)=O', 'CC(N(C)C)=O.CCOC(C)=O', '[C:11]([O:10][C:8](=[O:9])[NH:1][C:2]([C:5](=[O:7])[NH:69][C@H:58]([CH2:59][C:60]1[C:68]2[C:63](=[CH:64][CH:65]=[CH:66][CH:67]=2)[NH:62][CH:61]=1)[C:57]([N:53]1[CH2:54][CH2:55][CH2:56][C@@:51]([CH2:71][C:72]2[CH:77]=[CH:76][CH:75]=[CH:74][CH:73]=2)([C:49]([N:48]([CH3:78])[N:47]([CH3:79])[CH3:46])=[O:50])[CH2:52]1)=[O:70])([CH3:3])[CH3:4])([CH3:14])([CH3:13])[CH3:12] |f:2.3|']","['US20010041720A1', '0128', 'Boc-Aib-OH (11,9 g, 58,4 mmol) was dissolved in dimethylacetamide (125 ml) in a one-neck roundbottom flask (500 ml) equipped with a magnetic stirrer and nitrogen bubbler. To the stirred solution at room temperature were added 1-hydroxy-7-azabenzotriazole (7,95 g, 58,4 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimid hydrochloride (11,2 g, 58,4 mmol), and diisopropylethylamine (13,0 ml, 75,8 mmol). After 20 min. (yellow with precipitation) a solution of the product from step h which is either 1-[(2R)-2-amino-3-(1H-indol-3-yl)propionyl]-(3R)-3-benzylpiperidine-3-carboxylic acid trimethylhydrazide or 1-[(2R)-2-amino-3-(1H-indol-3-yl)propionyl]-(3S)-3-benzylpiperidine-3-carboxylic acid trimethylhydrazide (27,0 g, 58,4 mmol) in dimethylacetamide (125 ml) was added. The reaction was stirred at room temperature for 3 h. The mixture was added to EtOAc (750 ml) and washed with aqueous NaHSO4 (300 ml, 10%). The layers were allowed to separate, and the aqueous layer was re-extracted with EtOAc (500 ml). The combined organic layers were washed with H2O (100 ml), aqueous NaHCO3 (300 ml, saturated), H2O (100 ml), brine (300 ml), dried over MgSO4, filtered and concentrated in vacuo to approx. 500 ml. Then SiO2 (150 g) was added and the remaining EtOAc removed in vacuo to give a dry powder which was applied onto a filter packed with SiO2(150 g), washed with heptan (1 L), and the desired compound was liberated with EtOAc (2,5 L). After concentration in vacuo, the product which is either {1-[(1R)-2-[(3R)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)piperidin-1-yl]-1-(1H-indol-3-ylmethyl)-2-oxo-ethylcarbamoyl]-1-methylethyl}carbamic acid tert-butyl ester or {1-[(1R)-2-[(3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)piperidin-1-yl]-1-(1H--indol-3-ylmethyl)-2-oxo-ethylcarbamoyl]-1-methylethyl}carbamic acid tert-butyl ester 33,9 g as an orange foam was obtained.']","[{'chemical_names': ['Boc-Aib-OH'], 'identifiers': ['smiles:CC(C)(C)OC(=O)NC(C)(C)C(=O)O', 'inchi:InChI=1S/C9H17NO4/c1-8(2,3)14-7(13)10-9(4,5)6(11)12/h1-5H3,(H,10,13)(H,11,12)'], 'amounts': ['58,4 mmol', '11,9 g'], 'appearances': []}, {'chemical_names': ['1-hydroxy-7-azabenzotriazole'], 'identifiers': ['smiles:On1nnc2cccnc21', 'inchi:InChI=1S/C5H4N4O/c10-9-5-4(7-8-9)2-1-3-6-5/h1-3,10H'], 'amounts': ['58,4 mmol', '7,95 g'], 'appearances': []}, {'chemical_names': ['1-ethyl-3-(3-dimethylaminopropyl)carbodiimid hydrochloride'], 'identifiers': ['smiles:CCN=C=NCCCN(C)C.Cl', 'inchi:InChI=1S/C8H17N3.ClH/c1-4-9-8-10-6-5-7-11(2)3;/h4-7H2,1-3H3;1H'], 'amounts': ['58,4 mmol', '11,2 g'], 'appearances': []}, {'chemical_names': ['diisopropylethylamine'], 'identifiers': ['smiles:CCN(C(C)C)C(C)C', 'inchi:InChI=1S/C8H19N/c1-6-9(7(2)3)8(4)5/h7-8H,6H2,1-5H3'], 'amounts': ['75,8 mmol', '13,0 ml'], 'appearances': []}, {'chemical_names': ['1-[(2R)-2-amino-3-(1H-indol-3-yl)propionyl]-(3R)-3-benzylpiperidine-3-carboxylic acid trimethylhydrazide'], 'identifiers': ['smiles:CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@H](N)Cc2c[nH]c3ccccc23)C1', 'inchi:InChI=1S/C27H35N5O2/c1-30(2)31(3)26(34)27(17-20-10-5-4-6-11-20)14-9-15-32(19-27)25(33)23(28)16-21-18-29-24-13-8-7-12-22(21)24/h4-8,10-13,18,23,29H,9,14-17,19,28H2,1-3H3/t23-,27-/m1/s1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['1-[(2R)-2-amino-3-(1H-indol-3-yl)propionyl]-(3S)-3-benzylpiperidine-3-carboxylic acid trimethylhydrazide'], 'identifiers': ['smiles:CN(C)N(C)C(=O)[C@]1(Cc2ccccc2)CCCN(C(=O)[C@H](N)Cc2c[nH]c3ccccc23)C1', 'inchi:InChI=1S/C27H35N5O2/c1-30(2)31(3)26(34)27(17-20-10-5-4-6-11-20)14-9-15-32(19-27)25(33)23(28)16-21-18-29-24-13-8-7-12-22(21)24/h4-8,10-13,18,23,29H,9,14-17,19,28H2,1-3H3/t23-,27+/m1/s1'], 'amounts': ['58,4 mmol', '27,0 g'], 'appearances': []}, {'chemical_names': ['SiO2'], 'identifiers': [], 'amounts': ['150 g'], 'appearances': []}]","[{'chemical_names': ['{1-[(1R)-2-[(3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)piperidin-1-yl]-1-(1H--indol-3-ylmethyl)-2-oxo-ethylcarbamoyl]-1-methylethyl}carbamic acid tert-butyl ester'], 'identifiers': ['smiles:CN(C)N(C)C(=O)[C@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)NC(=O)OC(C)(C)C)C1', 'inchi:InChI=1S/C36H50N6O5/c1-34(2,3)47-33(46)39-35(4,5)31(44)38-29(21-26-23-37-28-18-13-12-17-27(26)28)30(43)42-20-14-19-36(24-42,32(45)41(8)40(6)7)22-25-15-10-9-11-16-25/h9-13,15-18,23,29,37H,14,19-22,24H2,1-8H3,(H,38,44)(H,39,46)/t29-,36+/m1/s1'], 'amounts': ['33,9 g'], 'appearances': ['orange']}]","[{'chemical_names': ['dimethylacetamide'], 'identifiers': ['smiles:CC(=O)N(C)C', 'inchi:InChI=1S/C4H9NO/c1-4(6)5(2)3/h1-3H3'], 'amounts': ['125 ml'], 'appearances': []}, {'chemical_names': ['dimethylacetamide'], 'identifiers': ['smiles:CC(=O)N(C)C', 'inchi:InChI=1S/C4H9NO/c1-4(6)5(2)3/h1-3H3'], 'amounts': ['125 ml'], 'appearances': []}, {'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['750 ml'], 'appearances': []}]",[],"['step 1:Boc-Aib-OH (11,9 g, 58,4 mmol) was dissolved in dimethylacetamide (125 ml) in a one-neck roundbottom flask (500 ml)', 'step 2:equipped with a magnetic stirrer', 'step 3:To the stirred solution at room temperature were added 1-hydroxy-7-azabenzotriazole (7,95 g, 58,4 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimid hydrochloride (11,2 g, 58,4 mmol), and diisopropylethylamine (13,0 ml, 75,8 mmol)', 'step 3 properties:Temperature:room temperature', 'step 4:After 20 min. (yellow with precipitation) a solution of the product from step h which', 'step 4 properties:Time:1200', 'step 5:was added', 'step 6:The reaction was stirred at room temperature for 3 h', 'step 6 properties:Time:10800', 'step 6 properties:Temperature:room temperature', 'step 7:The mixture was added to EtOAc (750 ml)', 'step 8:washed with aqueous NaHSO4 (300 ml, 10%)', 'step 9:to separate', 'step 10:the aqueous layer was re-extracted with EtOAc (500 ml)', 'step 11:The combined organic layers were washed with H2O (100 ml), aqueous NaHCO3 (300 ml, saturated), H2O (100 ml), brine (300 ml)', 'step 12:dried over MgSO4', 'step 13:filtered', 'step 14:concentrated in vacuo to approx. 500 ml', 'step 15:Then SiO2 (150 g) was added', 'step 16:the remaining EtOAc removed in vacuo', 'step 17:to give a dry powder which', 'step 18:washed with heptan (1 L)', 'step 19:After concentration in vacuo', 'step 20:{1-[(1R)-2-[(3S)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)piperidin-1-yl]-1-(1H--indol-3-ylmethyl)-2-oxo-ethylcarbamoyl]-1-methylethyl}carbamic acid tert-butyl ester 33,9 g as an orange foam was obtained']"
"['C[O:2][C:3](=[O:35])[C@H:4]([CH2:17][C:18]1[CH:23]=[CH:22][C:21]([NH:24][C:25]([C:27]2[C:32]([Cl:33])=[CH:31][CH:30]=[CH:29][C:28]=2[Cl:34])=[O:26])=[CH:20][CH:19]=1)[NH:5][C:6]([C:8]1([CH2:13][CH2:14][O:15][CH3:16])[CH2:12][CH2:11][CH2:10][CH2:9]1)=[S:7].[OH-].[Na+].Cl.C(OCC)(=O)C', 'CO.O', '[Cl:33][C:32]1[CH:31]=[CH:30][CH:29]=[C:28]([Cl:34])[C:27]=1[C:25]([NH:24][C:21]1[CH:22]=[CH:23][C:18]([CH2:17][C@@H:4]([C:3]([OH:35])=[O:2])[NH:5][C:6]([C:8]2([CH2:13][CH2:14][O:15][CH3:16])[CH2:12][CH2:11][CH2:10][CH2:9]2)=[S:7])=[CH:19][CH:20]=1)=[O:26] |f:1.2|']","['US20010041799A1', '0213', 'To a solution of 4-[[(2,6-dichlorophenyl)carbonyl]amino]-N-[[1-(2-methoxyethyl) cyclopentyl]thioxomethyl]-L-phenylalanine methyl ester (4.00 g, 7.44 mmol) in methanol (18 mL) was added a solution of NaOH (421 mg, 10.5 mmol) in water (3 mL). The mixture was stirred for 2 h and then acidified (pH ˜1-2) with 0.5N HCl. The reaction mixture was poured into a separatory funnel containing ethyl acetate (150 mL) and water (25 mL). The separated aqueous layer was back-extracted with ethyl acetate (2×50 mL). The combined organic layers was washed with brine, dried over MgSO4, filtered and concentrated in vacuo. Purification of the residual material by RP-HPLC (15-95% acetonitrile-water gradient over 25 min) provided 4-[[(2,6-dichlorophenyl)carbonyl]amino]-N-[[1 -(2-methoxyethyl)cyclopentyl]thioxomethyl]-L-phenylalanine (3.05 g, 78%). HR MS: Obs. mass, 545.1043. Calcd. mass, 545.1045 (M+Na).']","[{'chemical_names': ['4-[[(2,6-dichlorophenyl)carbonyl]amino]-N-[[1-(2-methoxyethyl) cyclopentyl]thioxomethyl]-L-phenylalanine methyl ester'], 'identifiers': ['smiles:COCCC1(C(=S)N[C@@H](Cc2ccc(NC(=O)c3c(Cl)cccc3Cl)cc2)C(=O)OC)CCCC1', 'inchi:InChI=1S/C26H30Cl2N2O4S/c1-33-15-14-26(12-3-4-13-26)25(35)30-21(24(32)34-2)16-17-8-10-18(11-9-17)29-23(31)22-19(27)6-5-7-20(22)28/h5-11,21H,3-4,12-16H2,1-2H3,(H,29,31)(H,30,35)/t21-/m0/s1'], 'amounts': ['7.44 mmol', '4.00 g'], 'appearances': []}, {'chemical_names': ['NaOH'], 'identifiers': ['smiles:[Na+].[OH-]', 'inchi:InChI=1S/Na.H2O/h;1H2/q+1;/p-1'], 'amounts': ['10.5 mmol', '421 mg'], 'appearances': []}, {'chemical_names': ['HCl'], 'identifiers': ['smiles:Cl', 'inchi:InChI=1S/ClH/h1H'], 'amounts': ['0.5N'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['150 mL'], 'appearances': []}]","[{'chemical_names': ['4-[[(2,6-dichlorophenyl)carbonyl]amino]-N-[[1 -(2-methoxyethyl)cyclopentyl]thioxomethyl]-L-phenylalanine'], 'identifiers': ['smiles:COCCC1(C(=S)N[C@@H](Cc2ccc(NC(=O)c3c(Cl)cccc3Cl)cc2)C(=O)O)CCCC1', 'inchi:InChI=1S/C25H28Cl2N2O4S/c1-33-14-13-25(11-2-3-12-25)24(34)29-20(23(31)32)15-16-7-9-17(10-8-16)28-22(30)21-18(26)5-4-6-19(21)27/h4-10,20H,2-3,11-15H2,1H3,(H,28,30)(H,29,34)(H,31,32)/t20-/m0/s1'], 'amounts': ['3.05 g', '78%', '78.3'], 'appearances': []}]","[{'chemical_names': ['methanol'], 'identifiers': ['smiles:CO', 'inchi:InChI=1S/CH4O/c1-2/h2H,1H3'], 'amounts': ['18 mL'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['3 mL'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['25 mL'], 'appearances': []}]",[],"['step 1:To a solution of 4-[[(2,6-dichlorophenyl)carbonyl]amino]-N-[[1-(2-methoxyethyl) cyclopentyl]thioxomethyl]-L-phenylalanine methyl ester (4.00 g, 7.44 mmol) in methanol (18 mL) was added a solution of NaOH (421 mg, 10.5 mmol) in water (3 mL)', 'step 2:The mixture was stirred for 2 h', 'step 2 properties:Time:7200', 'step 3:The reaction mixture was poured into a separatory funnel', 'step 4:containing ethyl acetate (150 mL) and water (25 mL)', 'step 5:The separated aqueous layer was back-extracted with ethyl acetate (2×50 mL)', 'step 6:The combined organic layers was washed with brine', 'step 7:dried over MgSO4', 'step 8:filtered', 'step 9:concentrated in vacuo', 'step 10:Purification of the residual material by RP-HPLC (15-95% acetonitrile-water gradient over 25 min)', 'step 10 properties:Time:1500', 'step 11:provided 4-[[(2,6-dichlorophenyl)carbonyl]amino]-N-[[1 -(2-methoxyethyl)cyclopentyl]thioxomethyl]-L-phenylalanine (3.05 g, 78%)']"
"['Cl.[CH3:2][O:3][C:4](=[O:17])[C@H:5]([CH2:7][C:8]1[CH:13]=[CH:12][C:11]([N+:14]([O-:16])=[O:15])=[CH:10][CH:9]=1)[NH2:6].[N:18]([CH2:21][CH2:22][C:23]1([C:28](O)=[O:29])[CH2:27][CH2:26][CH2:25][CH2:24]1)=[N+:19]=[N-:20].F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=CC=2N=N1.C(N(C(C)C)CC)(C)C', 'ClCCl.CN(C=O)C.O.C(OCC)(=O)C.CCCCCC', '[CH3:2][O:3][C:4](=[O:17])[C@H:5]([CH2:7][C:8]1[CH:13]=[CH:12][C:11]([N+:14]([O-:16])=[O:15])=[CH:10][CH:9]=1)[NH:6][C:28]([C:23]1([CH2:22][CH2:21][N:18]=[N+:19]=[N-:20])[CH2:27][CH2:26][CH2:25][CH2:24]1)=[O:29] |f:0.1,3.4|']","['US20010041799A1', '0219', 'A solution of 4-nitro-L-phenylalanine methyl ester hydrochloride (3.0 g, 11.5 mmol), 1-(2-azidoethyl)cyclopentane carboxylic acid (2.3 g, 12.7 mmol) and BOP (5.34 g, 12.1 mmol) in dichloromethane (6 mL) and DMF (4 mL) was treated with diisopropylethylamine (4.2 mL, 24.2 mmol). The mixture was stirred overnight at which time TLC (1:1 hexane:ethyl acetate) indicated no more starting material. The mixture was diluted with water, extracted with ethyl acetate. The extracts were washed with water and brine, then were dried (Na2SO4), filtered and evaporated in vacuo. The residue was purified by chromatography over silica gel (3:1 hexane:ethyl acetate) to afford 4.26 g of N-[[1-(2-azidoethyl)cyclopentyl]carbonyl]-4-nitro-L-phenylalanine methyl ester.']","[{'chemical_names': ['4-nitro-L-phenylalanine methyl ester hydrochloride'], 'identifiers': ['smiles:COC(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1.Cl', 'inchi:InChI=1S/C10H12N2O4.ClH/c1-16-10(13)9(11)6-7-2-4-8(5-3-7)12(14)15;/h2-5,9H,6,11H2,1H3;1H/t9-;/m0./s1'], 'amounts': ['11.5 mmol', '3.0 g'], 'appearances': []}, {'chemical_names': ['1-(2-azidoethyl)cyclopentane carboxylic acid'], 'identifiers': ['smiles:[N-]=[N+]=NCCC1(C(=O)O)CCCC1', 'inchi:InChI=1S/C8H13N3O2/c9-11-10-6-5-8(7(12)13)3-1-2-4-8/h1-6H2,(H,12,13)'], 'amounts': ['12.7 mmol', '2.3 g'], 'appearances': []}, {'chemical_names': ['BOP'], 'identifiers': ['smiles:CN(C)[P+](On1nnc2ccccc21)(N(C)C)N(C)C.F[P-](F)(F)(F)(F)F', 'inchi:InChI=1S/C12H22N6OP.F6P/c1-15(2)20(16(3)4,17(5)6)19-18-12-10-8-7-9-11(12)13-14-18;1-7(2,3,4,5)6/h7-10H,1-6H3;/q+1;-1'], 'amounts': ['12.1 mmol', '5.34 g'], 'appearances': []}, {'chemical_names': ['diisopropylethylamine'], 'identifiers': ['smiles:CCN(C(C)C)C(C)C', 'inchi:InChI=1S/C8H19N/c1-6-9(7(2)3)8(4)5/h7-8H,6H2,1-5H3'], 'amounts': ['24.2 mmol', '4.2 mL'], 'appearances': []}]","[{'chemical_names': ['N-[[1-(2-azidoethyl)cyclopentyl]carbonyl]-4-nitro-L-phenylalanine methyl ester'], 'identifiers': ['smiles:COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)C1(CCN=[N+]=[N-])CCCC1', 'inchi:InChI=1S/C18H23N5O5/c1-28-16(24)15(12-13-4-6-14(7-5-13)23(26)27)21-17(25)18(8-2-3-9-18)10-11-20-22-19/h4-7,15H,2-3,8-12H2,1H3,(H,21,25)/t15-/m0/s1'], 'amounts': ['4.26 g', '95.1'], 'appearances': []}]","[{'chemical_names': ['dichloromethane'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['6 mL'], 'appearances': []}, {'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['4 mL'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['hexane'], 'identifiers': ['smiles:CCCCCC', 'inchi:InChI=1S/C6H14/c1-3-5-6-4-2/h3-6H2,1-2H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:A solution of 4-nitro-L-phenylalanine methyl ester hydrochloride (3.0 g, 11.5 mmol), 1-(2-azidoethyl)cyclopentane carboxylic acid (2.3 g, 12.7 mmol) and BOP (5.34 g, 12.1 mmol) in dichloromethane (6 mL) and DMF (4 mL) was treated with diisopropylethylamine (4.2 mL, 24.2 mmol)', 'step 2:The mixture was stirred overnight at which time TLC (1:1 hexane:ethyl acetate)', 'step 2 properties:Time:overnight', 'step 3:The mixture was diluted with water', 'step 4:extracted with ethyl acetate', 'step 5:The extracts were washed with water and brine', 'step 6:were dried (Na2SO4)', 'step 7:filtered', 'step 8:evaporated in vacuo', 'step 9:The residue was purified by chromatography over silica gel (3:1 hexane:ethyl acetate)', 'step 10:to afford 4.26 g of N-[[1-(2-azidoethyl)cyclopentyl]carbonyl]-4-nitro-L-phenylalanine methyl ester']"
"['[CH3:1][O:2][C:3](=[O:29])[C@H:4]([CH2:19][C:20]1[CH:25]=[CH:24][C:23]([N+]([O-])=O)=[CH:22][CH:21]=1)[NH:5]C(C1(CCNC(=O)C)CCCC1)=S.O.ClCCl.CC(C)=O', 'CO.C(OCC)(=O)C.[Cl-].[NH4+].[Zn]', '[CH3:1][O:2][C:3](=[O:29])[C@H:4]([CH2:19][C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1)[NH2:5] |f:2.3,6.7|']","['US20010041799A1', '0229', 'To a suspension of N-[[1-[2-(acetylamino)ethyl]cyclopentyl]thioxomethyl]-4-nitro-L-phenylalanine methyl ester (740 mg, 1.75 mmol), zinc dust (1.14 g, 17.5 mmol) and ammonium chloride (1.41 g, 26.3 mmol) in methanol (20 mL) was added H2O (10 mL) slowly over 5 min. After stirring for 20 min, the reaction mixture was diluted with ethyl acetate (80 mL) and sat. ammonium chloride solution (25 mL). The separated aqueous layer was back-extracted with ethyl acetate (3×25 mL) and the organic layers were combined, dried over Na2SO4, filtered and concentrated in vacuo. The residual oil was dried under high vacuum for 2 h to give the crude amine (750 mg)which was by flash silica gel column chromatography (dichloromethane-acetone 2:1) to furnish 4-amino-N-[[l-[2-acetylamino)ethyl]cyclopentyl]thioxomethyl]-L-phenylalanine methyl ester (650 mg, 95%). HR MS: Obs. mass, 392.2016. Calcd. mass, 392.2008 (M+H).']","[{'chemical_names': ['N-[[1-[2-(acetylamino)ethyl]cyclopentyl]thioxomethyl]-4-nitro-L-phenylalanine methyl ester'], 'identifiers': ['smiles:COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=S)C1(CCNC(C)=O)CCCC1', 'inchi:InChI=1S/C20H27N3O5S/c1-14(24)21-12-11-20(9-3-4-10-20)19(29)22-17(18(25)28-2)13-15-5-7-16(8-6-15)23(26)27/h5-8,17H,3-4,9-13H2,1-2H3,(H,21,24)(H,22,29)/t17-/m0/s1'], 'amounts': ['1.75 mmol', '740 mg'], 'appearances': []}, {'chemical_names': ['H2O'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['10 mL'], 'appearances': []}, {'chemical_names': ['dichloromethane acetone'], 'identifiers': ['smiles:CC(C)=O.ClCCl', 'inchi:InChI=1S/C3H6O.CH2Cl2/c1-3(2)4;2-1-3/h1-2H3;1H2'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['L-phenylalanine methyl ester'], 'identifiers': ['smiles:COC(=O)[C@@H](N)Cc1ccccc1', 'inchi:InChI=1S/C10H13NO2/c1-13-10(12)9(11)7-8-5-3-2-4-6-8/h2-6,9H,7,11H2,1H3/t9-/m0/s1'], 'amounts': ['650 mg', '95%', '207.3'], 'appearances': []}]","[{'chemical_names': ['methanol'], 'identifiers': ['smiles:CO', 'inchi:InChI=1S/CH4O/c1-2/h2H,1H3'], 'amounts': ['20 mL'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['80 mL'], 'appearances': []}, {'chemical_names': ['ammonium chloride'], 'identifiers': ['smiles:[Cl-].[NH4+]', 'inchi:InChI=1S/ClH.H3N/h1H;1H3'], 'amounts': ['25 mL'], 'appearances': []}, {'chemical_names': ['ammonium chloride'], 'identifiers': ['smiles:[Cl-].[NH4+]', 'inchi:InChI=1S/ClH.H3N/h1H;1H3'], 'amounts': ['26.3 mmol', '1.41 g'], 'appearances': []}]","[{'chemical_names': ['zinc'], 'identifiers': ['smiles:[Zn]', 'inchi:InChI=1S/Zn'], 'amounts': ['17.5 mmol', '1.14 g'], 'appearances': []}]","['step 1:To a suspension of N-[[1-[2-(acetylamino)ethyl]cyclopentyl]thioxomethyl]-4-nitro-L-phenylalanine methyl ester (740 mg, 1.75 mmol), zinc dust (1.14 g, 17.5 mmol) and ammonium chloride (1.41 g, 26.3 mmol) in methanol (20 mL)', 'step 2:was added H2O (10 mL) slowly over 5 min', 'step 2 properties:Time:300', 'step 3:After stirring for 20 min', 'step 3 properties:Time:1200', 'step 4:the reaction mixture was diluted with ethyl acetate (80 mL) and sat. ammonium chloride solution (25 mL)', 'step 5:The separated aqueous layer was back-extracted with ethyl acetate (3×25 mL)', 'step 6:dried over Na2SO4', 'step 7:filtered', 'step 8:concentrated in vacuo', 'step 9:The residual oil was dried under high vacuum for 2 h', 'step 9 properties:Time:7200', 'step 10:to give the crude amine (750 mg)which', 'step 11:to furnish 4-amino-N-[[l-[2-acetylamino)ethyl]cyclopentyl]thioxomethyl]-L-phenylalanine methyl ester (650 mg, 95%)']"
"['Cl.[CH3:2][O:3][C:4](=[O:17])[C@H:5]([CH2:7][C:8]1[CH:13]=[CH:12][C:11]([N+:14]([O-:16])=[O:15])=[CH:10][CH:9]=1)[NH2:6].[Cl:18][C:19]1[CH:27]=[CH:26][CH:25]=[C:24]([CH3:28])[C:20]=1[C:21](O)=[O:22].CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(C(C)C)CC)(C)C', 'CN(C=O)C.C(OCC)(=O)C', '[CH3:2][O:3][C:4](=[O:17])[C@H:5]([CH2:7][C:8]1[CH:13]=[CH:12][C:11]([N+:14]([O-:16])=[O:15])=[CH:10][CH:9]=1)[NH:6][C:21]([C:20]1[C:24]([CH3:28])=[CH:25][CH:26]=[CH:27][C:19]=1[Cl:18])=[O:22] |f:0.1,3.4|']","['US20010041799A1', '0240', 'To a solution of 4-nitro-L-phenylalanine methyl ester hydrochloride salt (7.44 mmol, 1.94 g), 2-chloro-6-methylbenzoic acid (8.2 mmol, 1.4 g) and HBTU (8.2 mmol, 3.11 g) in DMF (27 mL) was added diisopropylethylamine (18.6 mmol, 3.24 mL) at room temperature. The clear solution was stirred for 48 h at room temperature and was diluted with 100 mL of ethyl acetate. The solution was washed in turn with 0.5N hydrochloric acid (2×50 mL), saturated sodium bicarbonate solution (2 x 50 mL), brine (100 mL) then was dried (MgSO4) and filtered. Concentration of the solution to dryness gave 2.67 g (95%) of N-[(2-chloro-6-methylphenyl)carbonyl]-4-nitro-L-phenylalanine methyl ester as a colorless solid, mp 120-123° C. HRMS: Obs. mass, 376.4274. Calcd. mass, 376.4238 (M+H).']","[{'chemical_names': ['4-nitro-L-phenylalanine methyl ester hydrochloride salt'], 'identifiers': ['smiles:COC(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1.Cl', 'inchi:InChI=1S/C10H12N2O4.ClH/c1-16-10(13)9(11)6-7-2-4-8(5-3-7)12(14)15;/h2-5,9H,6,11H2,1H3;1H/t9-;/m0./s1'], 'amounts': ['7.44 mmol', '1.94 g'], 'appearances': []}, {'chemical_names': ['2-chloro-6-methylbenzoic acid'], 'identifiers': ['smiles:Cc1cccc(Cl)c1C(=O)O', 'inchi:InChI=1S/C8H7ClO2/c1-5-3-2-4-6(9)7(5)8(10)11/h2-4H,1H3,(H,10,11)'], 'amounts': ['8.2 mmol', '1.4 g'], 'appearances': []}, {'chemical_names': ['HBTU'], 'identifiers': ['smiles:CN(C)C(On1nnc2ccccc21)=[N+](C)C.F[P-](F)(F)(F)(F)F', 'inchi:InChI=1S/C11H16N5O.F6P/c1-14(2)11(15(3)4)17-16-10-8-6-5-7-9(10)12-13-16;1-7(2,3,4,5)6/h5-8H,1-4H3;/q+1;-1'], 'amounts': ['8.2 mmol', '3.11 g'], 'appearances': []}, {'chemical_names': ['diisopropylethylamine'], 'identifiers': ['smiles:CCN(C(C)C)C(C)C', 'inchi:InChI=1S/C8H19N/c1-6-9(7(2)3)8(4)5/h7-8H,6H2,1-5H3'], 'amounts': ['18.6 mmol', '3.24 mL'], 'appearances': []}]","[{'chemical_names': ['N-[(2-chloro-6-methylphenyl)carbonyl]-4-nitro-L-phenylalanine methyl ester'], 'identifiers': ['smiles:COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1c(C)cccc1Cl', 'inchi:InChI=1S/C18H17ClN2O5/c1-11-4-3-5-14(19)16(11)17(22)20-15(18(23)26-2)10-12-6-8-13(9-7-12)21(24)25/h3-9,15H,10H2,1-2H3,(H,20,22)/t15-/m0/s1'], 'amounts': ['2.67 g', '95%', '95.2'], 'appearances': ['colorless']}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['27 mL'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['100 mL'], 'appearances': []}]",[],"['step 1:To a solution of 4-nitro-L-phenylalanine methyl ester hydrochloride salt (7.44 mmol, 1.94 g), 2-chloro-6-methylbenzoic acid (8.2 mmol, 1.4 g) and HBTU (8.2 mmol, 3.11 g) in DMF (27 mL) was added diisopropylethylamine (18.6 mmol, 3.24 mL) at room temperature', 'step 1 properties:Temperature:room temperature', 'step 2:The clear solution was stirred for 48 h at room temperature', 'step 2 properties:Time:172800', 'step 2 properties:Temperature:room temperature', 'step 3:was diluted with 100 mL of ethyl acetate', 'step 4:The solution was washed in turn with 0.5N hydrochloric acid (2×50 mL), saturated sodium bicarbonate solution (2 x 50 mL), brine (100 mL)', 'step 5:then was dried (MgSO4)', 'step 6:filtered', 'step 7:Concentration of the solution to dryness gave 2.67 g (95%) of N-[(2-chloro-6-methylphenyl)carbonyl]-4-nitro-L-phenylalanine methyl ester as a colorless solid, mp 120-123° C']"
"['[CH3:1][O:2][C:3](=[O:26])[C@H:4]([CH2:16][C:17]1[CH:22]=[CH:21][C:20]([N+:23]([O-:25])=[O:24])=[CH:19][CH:18]=1)[NH:5][C:6]([C:8]1[C:13]([CH3:14])=[CH:12][CH:11]=[CH:10][C:9]=1[Cl:15])=O.COC1C=CC(P2(SP(C3C=CC(OC)=CC=3)(=S)S2)=[S:36])=CC=1.C1(C)C=CC=CC=1', 'C(OCC)(=O)C', '[CH3:1][O:2][C:3](=[O:26])[C@H:4]([CH2:16][C:17]1[CH:22]=[CH:21][C:20]([N+:23]([O-:25])=[O:24])=[CH:19][CH:18]=1)[NH:5][C:6]([C:8]1[C:13]([CH3:14])=[CH:12][CH:11]=[CH:10][C:9]=1[Cl:15])=[S:36]']","['US20010041799A1', 'N-[(2-chloro-6-methylphenyl)thioxomethyl]-4-nitro-L-phenylalanine methyl ester.', '0242', ""To a mixture of N-[(2-chloro-6-methylphenyl)carbonyl]-4-nitro-L-phenylalanine methyl ester (9.66 mmol, 3.64 g) and Lawesson's reagent (6.0 mmol, 2.46 g, 0.62 equiv.) was added toluene (15 mL, which had been stored over 4 A molecular sieves) at room temperature. The suspension was heated to 90-100° C. and was stirred for 24 h. Examination of the resulting clear solution by TLC failed to detect the presence of starting material. The reaction mixture was diluted with ethyl acetate (50 mL) and washed with water (50 mL), saturated sodium bicarbonate solution (50 mL), and brine (50 mL). The organic extract was dried (MgSO4) filtered and evaporated under reduced pressure. The crude compound was purified by careful silica gel column chromatography (hexane:ethyl acetate, 4:1 to 2:1) to obtain 1.52 g (40%) of N-[(2-chloro-6-methylphenyl)thioxomethyl]-4-nitro-L-phenylalanine methyl ester as a yellow solid, mp 150-153° C. (triturated from diethyl ether/ hexane 3:1 ratio). HRMS: Obs. mass, 393.0685. Calcd. mass, 393.0677 (M+H).""]","[{'chemical_names': ['N-[(2-chloro-6-methylphenyl)carbonyl]-4-nitro-L-phenylalanine methyl ester'], 'identifiers': ['smiles:COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1c(C)cccc1Cl', 'inchi:InChI=1S/C18H17ClN2O5/c1-11-4-3-5-14(19)16(11)17(22)20-15(18(23)26-2)10-12-6-8-13(9-7-12)21(24)25/h3-9,15H,10H2,1-2H3,(H,20,22)/t15-/m0/s1'], 'amounts': ['9.66 mmol', '3.64 g'], 'appearances': []}, {'chemical_names': [""Lawesson's reagent""], 'identifiers': ['smiles:COc1ccc(P2(=S)SP(=S)(c3ccc(OC)cc3)S2)cc1', 'inchi:InChI=1S/C14H14O2P2S4/c1-15-11-3-7-13(8-4-11)17(19)21-18(20,22-17)14-9-5-12(16-2)6-10-14/h3-10H,1-2H3'], 'amounts': ['6.0 mmol', '2.46 g', '0.62 equiv.'], 'appearances': []}, {'chemical_names': ['toluene'], 'identifiers': ['smiles:Cc1ccccc1', 'inchi:InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['N-[(2-chloro-6-methylphenyl)thioxomethyl]-4-nitro-L-phenylalanine methyl ester'], 'identifiers': ['smiles:COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=S)c1c(C)cccc1Cl', 'inchi:InChI=1S/C18H17ClN2O4S/c1-11-4-3-5-14(19)16(11)17(26)20-15(18(22)25-2)10-12-6-8-13(9-7-12)21(23)24/h3-9,15H,10H2,1-2H3,(H,20,26)/t15-/m0/s1'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['50 mL'], 'appearances': []}]",[],"[""step 1:To a mixture of N-[(2-chloro-6-methylphenyl)carbonyl]-4-nitro-L-phenylalanine methyl ester (9.66 mmol, 3.64 g) and Lawesson's reagent (6.0 mmol, 2.46 g, 0.62 equiv.)"", 'step 2:was added toluene (15 mL, which', 'step 3:at room temperature', 'step 3 properties:Temperature:room temperature', 'step 4:The suspension was heated to 90-100° C.', 'step 4 properties:Temperature:90 to 100', 'step 5:was stirred for 24 h', 'step 5 properties:Time:86400', 'step 6:The reaction mixture was diluted with ethyl acetate (50 mL)', 'step 7:washed with water (50 mL), saturated sodium bicarbonate solution (50 mL), and brine (50 mL)', 'step 8:The organic extract', 'step 9:was dried (MgSO4)', 'step 10:filtered', 'step 11:evaporated under reduced pressure', 'step 11 properties:Pressure:reduced pressure', 'step 12:The crude compound was purified by careful silica gel column chromatography (hexane:ethyl acetate, 4:1 to 2:1)', 'step 13:to obtain', 'step 14:1.52 g (40%) of N-[(2-chloro-6-methylphenyl)thioxomethyl]-4-nitro-L-phenylalanine methyl ester as a yellow solid, mp 150-153° C. (triturated from diethyl ether/ hexane 3:1 ratio)']"
"['Cl.[CH3:2][O:3][C:4](=[O:17])[C@H:5]([CH2:7][C:8]1[CH:13]=[CH:12][C:11]([N+:14]([O-:16])=[O:15])=[CH:10][CH:9]=1)[NH2:6].[CH3:18][S:19][CH2:20][CH2:21][CH2:22][CH2:23][C:24]1([C:29](O)=[O:30])[CH2:28][CH2:27][CH2:26][CH2:25]1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(C(C)C)CC)(C)C', 'CN(C=O)C.C(OCC)(=O)C', '[CH3:2][O:3][C:4](=[O:17])[C@H:5]([CH2:7][C:8]1[CH:13]=[CH:12][C:11]([N+:14]([O-:16])=[O:15])=[CH:10][CH:9]=1)[NH:6][C:29]([C:24]1([CH2:23][CH2:22][CH2:21][CH2:20][S:19][CH3:18])[CH2:28][CH2:27][CH2:26][CH2:25]1)=[O:30] |f:0.1,3.4|']","['US20010041799A1', '0302', 'To a suspension of 4-nitro-L-phenylalanine methyl ester hydrochloride salt (181.84 mmol, 47.41 g), 1-[4-(methylthio)butyl]cyclopentanecarboxylic acid (177.17 mmol, 38.33 g) in DMF (470 mL) were added HBTU (177.17 mmol, 67.2 g) and diisopropylethylamine (443 mmol, 77 mL) at room temperature. The clear solution was stirred for 15 h at room temperature at which time TLC analysis of the mixture indicated the absence of starting materials. The reaction mixture was diluted with 600 mL of ethyl acetate then was washed in turn with 0.5N hydrochloric acid (2×250 mL), saturated sodium bicarbonate solution (2×250 mL) and brine (300 mL). The dried (MgSO4) organic layer was filtered and evaporated to dryness under reduced pressure. The crude product which was purified by silica gel column chromatography to afford 58.5 g (78%) of N-[[1-[4-(methylthio)butyl]cyclopentyl]carbonyl]-4-nitro-L-phenylalanine methyl ester as an amorphous colorless solid. HRMS: Obs. mass, 423.1940. Calcd. mass, 423.1953 (M+H).']","[{'chemical_names': ['4-nitro-L-phenylalanine methyl ester hydrochloride salt'], 'identifiers': ['smiles:COC(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1.Cl', 'inchi:InChI=1S/C10H12N2O4.ClH/c1-16-10(13)9(11)6-7-2-4-8(5-3-7)12(14)15;/h2-5,9H,6,11H2,1H3;1H/t9-;/m0./s1'], 'amounts': ['181.84 mmol', '47.41 g'], 'appearances': []}, {'chemical_names': ['1-[4-(methylthio)butyl]cyclopentanecarboxylic acid'], 'identifiers': ['smiles:CSCCCCC1(C(=O)O)CCCC1', 'inchi:InChI=1S/C11H20O2S/c1-14-9-5-4-8-11(10(12)13)6-2-3-7-11/h2-9H2,1H3,(H,12,13)'], 'amounts': ['177.17 mmol', '38.33 g'], 'appearances': []}, {'chemical_names': ['HBTU'], 'identifiers': ['smiles:CN(C)C(On1nnc2ccccc21)=[N+](C)C.F[P-](F)(F)(F)(F)F', 'inchi:InChI=1S/C11H16N5O.F6P/c1-14(2)11(15(3)4)17-16-10-8-6-5-7-9(10)12-13-16;1-7(2,3,4,5)6/h5-8H,1-4H3;/q+1;-1'], 'amounts': ['177.17 mmol', '67.2 g'], 'appearances': []}, {'chemical_names': ['diisopropylethylamine'], 'identifiers': ['smiles:CCN(C(C)C)C(C)C', 'inchi:InChI=1S/C8H19N/c1-6-9(7(2)3)8(4)5/h7-8H,6H2,1-5H3'], 'amounts': ['443 mmol', '77 mL'], 'appearances': []}]","[{'chemical_names': ['N-[[1-[4-(methylthio)butyl]cyclopentyl]carbonyl]-4-nitro-L-phenylalanine methyl ester'], 'identifiers': ['smiles:COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)C1(CCCCSC)CCCC1', 'inchi:InChI=1S/C21H30N2O5S/c1-28-19(24)18(15-16-7-9-17(10-8-16)23(26)27)22-20(25)21(11-3-4-12-21)13-5-6-14-29-2/h7-10,18H,3-6,11-15H2,1-2H3,(H,22,25)/t18-/m0/s1'], 'amounts': ['58.5 g', '78%', '78.1'], 'appearances': ['amorphous colorless']}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['470 mL'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['600 mL'], 'appearances': []}]",[],"['step 1:To a suspension of 4-nitro-L-phenylalanine methyl ester hydrochloride salt (181.84 mmol, 47.41 g), 1-[4-(methylthio)butyl]cyclopentanecarboxylic acid (177.17 mmol, 38.33 g) in DMF (470 mL)', 'step 2:were added HBTU (177.17 mmol, 67.2 g) and diisopropylethylamine (443 mmol, 77 mL) at room temperature', 'step 2 properties:Temperature:room temperature', 'step 3:The clear solution was stirred for 15 h at room temperature at which time TLC analysis of the mixture', 'step 3 properties:Time:54000', 'step 3 properties:Temperature:room temperature', 'step 4:The reaction mixture was diluted with 600 mL of ethyl acetate', 'step 5:then was washed in turn with 0.5N hydrochloric acid (2×250 mL), saturated sodium bicarbonate solution (2×250 mL) and brine (300 mL)', 'step 6:The dried (MgSO4) organic layer', 'step 7:was filtered', 'step 8:evaporated to dryness under reduced pressure', 'step 8 properties:Pressure:reduced pressure', 'step 9:The crude product which was purified by silica gel column chromatography', 'step 10:to afford 58.5 g (78%) of N-[[1-[4-(methylthio)butyl]cyclopentyl]carbonyl]-4-nitro-L-phenylalanine methyl ester as an amorphous colorless solid']"
"['[NH2:1][C:2]1[CH:25]=[CH:24][C:5]2[C:6]3[C:19]([O:20][CH:21]([F:23])[F:22])=[CH:18][CH:17]=[CH:16][C:7]=3[O:8][CH:9]([C:10]3[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=3)[C:4]=2[C:3]=1Br.C(N(CC)CC)C.[H][H]', 'C(OCC)(=O)C.[Pd]', '[NH2:1][C:2]1[CH:25]=[CH:24][C:5]2[C:6]3[C:19]([O:20][CH:21]([F:23])[F:22])=[CH:18][CH:17]=[CH:16][C:7]=3[O:8][CH:9]([C:10]3[CH:11]=[CH:12][CH:13]=[CH:14][CH:15]=3)[C:4]=2[CH:3]=1']","['US20010041802A1', '8-Amino-1-difluoromethoxy-6-phenyl-6H-dibenzo[b,d]pyran', '0208', 'A solution of Example 4 (1.19 g), triethylamine (2.8 mL) and 10% Pd/C (120 mg) in ethyl acetate (100 mL) was shaken under 1.5 atms. hydrogen for 15 minutes. The mixture was filtered and concentrated under reduced pressure. The residue was taken up in toluene (50 mL), washed with aqueous KHCO3, dried (Na2SO4), filtered and concentrated. The resulting material was purified on silica eluting with 25% hexane −75% CH2Cl2 to provide the titled compound (0.763 g, 80%). 1H NMR (300 MHz, CDCl3) δ 3.75 (br s, 2H), 5.95 (s, 1H), 6.14 (d, J=3 Hz, 1H), 6.50 (t, J=75 Hz, 1H, CHF2) 6.71 (dd, J=9 Hz, 3 Hz, 1H), 6.77 (dd, J=9 Hz, 1Hz, 1H), 6.87 (dd, J=9 Hz, 1Hz, 1H), 7.05 (t, J=8 Hz, H), 7.30-7.40 (m, 5H), 8.12 (d, J=9 Hz, 1H). MS (APCI) m/e 340 (M+H).']","[{'chemical_names': ['solution', '8-Amino-7-bromo-1-difluoromethoxy-6-phenyl-6H-dibenzo[b,d]pyran'], 'identifiers': ['smiles:Nc1ccc2c(c1Br)C(c1ccccc1)Oc1cccc(OC(F)F)c1-2', 'inchi:InChI=1S/C20H14BrF2NO2/c21-18-13(24)10-9-12-16-14(7-4-8-15(16)26-20(22)23)25-19(17(12)18)11-5-2-1-3-6-11/h1-10,19-20H,24H2'], 'amounts': ['1.19 g'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['2.8 mL'], 'appearances': []}, {'chemical_names': ['hydrogen'], 'identifiers': ['smiles:[H][H]', 'inchi:InChI=1S/H2/h1H'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['titled compound', '8-Amino-1-difluoromethoxy-6-phenyl-6H-dibenzo[b,d]pyran'], 'identifiers': ['smiles:Nc1ccc2c(c1)C(c1ccccc1)Oc1cccc(OC(F)F)c1-2', 'inchi:InChI=1S/C20H15F2NO2/c21-20(22)25-17-8-4-7-16-18(17)14-10-9-13(23)11-15(14)19(24-16)12-5-2-1-3-6-12/h1-11,19-20H,23H2'], 'amounts': ['0.763 g', '80%', '79.0'], 'appearances': []}]","[{'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['100 mL'], 'appearances': []}]","[{'chemical_names': ['Pd/C'], 'identifiers': ['smiles:[Pd]', 'inchi:InChI=1S/Pd'], 'amounts': ['120 mg'], 'appearances': []}]","['step 1:A solution of Example 4 (1.19 g), triethylamine (2.8 mL) and 10% Pd/C (120 mg) in ethyl acetate (100 mL) was shaken under 1.5 atms', 'step 2:hydrogen for 15 minutes', 'step 2 properties:Time:900', 'step 3:The mixture was filtered', 'step 4:concentrated under reduced pressure', 'step 4 properties:Pressure:reduced pressure', 'step 5:washed with aqueous KHCO3', 'step 6:dried (Na2SO4)', 'step 7:filtered', 'step 8:concentrated', 'step 9:The resulting material was purified on silica eluting with 25% hexane −75% CH2Cl2', 'step 10:to provide the titled compound (0.763 g, 80%)']"
"['[CH2:1]([O:8][C:9]([NH:11][C:12]1[CH:30]=[CH:29][C:15]2[C:16]3[C:24]([O:25][CH:26]([F:28])[F:27])=[CH:23][CH:22]=[CH:21][C:17]=3[O:18][C:19](=[O:20])[C:14]=2[C:13]=1[Br:31])=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[H-].CCCCCCC.C(C(C(C([O-])=O)O)O)([O-])=O.[K+].[Na+]', 'ClCCl.C(OCC)(=O)C', '[CH2:1]([O:8][C:9]([NH:11][C:12]1[CH:30]=[CH:29][C:15]2[C:16]3[C:24]([O:25][CH:26]([F:28])[F:27])=[CH:23][CH:22]=[CH:21][C:17]=3[O:18][CH:19]([OH:20])[C:14]=2[C:13]=1[Br:31])=[O:10])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1 |f:3.4.5|']","['US20010041802A1', '8-benzyloxycarbonylamino-7-bromo-1-difluoromethoxy-6H-dibenzo(b,d)pyran-6-ol', '0215', 'A solution of Example 27D (0.52 g, 1.08 mmol) in dichloromethane (100 mL) at −78° C. was treated with disobutylaluminum hydride in heptane (1.30 mL, 1.30 mmol), stirred for 30 minutes at −78° C., and treated with ethyl acetate (10 mL) and sodium potassium tartrate (50 mL) to provide two layers. The layers were separated, and the aqueous layer was extracted with ethyl acetate. The extract was dried (Na2SO4), filtered, and concentrated. The concentrate was purified by flash column chromatography on silica gel with 20-50% ethyl acetate/hexanes to provide the desired product. MS (ESI(−)Q1MS) m/z 490 (M-H)−.']","[{'chemical_names': ['solution', '8-benzyloxycarbonylamino-7-bromo-1-difluoromethoxy-6H-dibenzo(b,d)pyran-6-one'], 'identifiers': ['smiles:O=C(Nc1ccc2c(c1Br)c(=O)oc1cccc(OC(F)F)c12)OCc1ccccc1', 'inchi:InChI=1S/C22H14BrF2NO5/c23-19-14(26-22(28)29-11-12-5-2-1-3-6-12)10-9-13-17-15(30-20(27)18(13)19)7-4-8-16(17)31-21(24)25/h1-10,21H,11H2,(H,26,28)'], 'amounts': ['1.08 mmol', '0.52 g'], 'appearances': []}, {'chemical_names': ['hydride'], 'identifiers': ['smiles:[H-]', 'inchi:InChI=1S/H/q-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['heptane'], 'identifiers': ['smiles:CCCCCCC', 'inchi:InChI=1S/C7H16/c1-3-5-7-6-4-2/h3-7H2,1-2H3'], 'amounts': ['1.30 mmol', '1.30 mL'], 'appearances': []}, {'chemical_names': ['sodium potassium tartrate'], 'identifiers': ['smiles:O=C([O-])C(O)C(O)C(=O)[O-].[K+].[Na+]', 'inchi:InChI=1S/C4H6O6.K.Na/c5-1(3(7)8)2(6)4(9)10;;/h1-2,5-6H,(H,7,8)(H,9,10);;/q;2*+1/p-2'], 'amounts': ['50 mL'], 'appearances': []}]","[{'chemical_names': ['desired product', '8-benzyloxycarbonylamino-7-bromo-1-difluoromethoxy-6H-dibenzo(b,d)pyran-6-ol'], 'identifiers': ['smiles:O=C(Nc1ccc2c(c1Br)C(O)Oc1cccc(OC(F)F)c1-2)OCc1ccccc1', 'inchi:InChI=1S/C22H16BrF2NO5/c23-19-14(26-22(28)29-11-12-5-2-1-3-6-12)10-9-13-17-15(30-20(27)18(13)19)7-4-8-16(17)31-21(24)25/h1-10,20-21,27H,11H2,(H,26,28)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['dichloromethane'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['100 mL'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['10 mL'], 'appearances': []}]",[],"['step 1:A solution of Example 27D (0.52 g, 1.08 mmol) in dichloromethane (100 mL) at −78° C. was treated with disobutylaluminum hydride in heptane (1.30 mL, 1.30 mmol)', 'step 1 properties:Temperature:-78', 'step 2:stirred for 30 minutes at −78° C.', 'step 2 properties:Time:1800', 'step 2 properties:Temperature:-78', 'step 3:treated with ethyl acetate (10 mL) and sodium potassium tartrate (50 mL)', 'step 4:to provide two layers', 'step 5:The layers were separated', 'step 6:the aqueous layer was extracted with ethyl acetate', 'step 7:The extract was dried (Na2SO4)', 'step 8:filtered', 'step 9:concentrated', 'step 10:The concentrate was purified by flash column chromatography on silica gel with 20-50% ethyl acetate/hexanes', 'step 11:to provide the desired product']"
"['[CH3:1][O:2][C:3]1[C:12]2[C:11]3[CH:13]=[CH:14][C:15]([CH2:17][S:18]([NH2:21])(=[O:20])=[O:19])=[CH:16][C:10]=3[CH:9]([C:22]3[CH:27]=[CH:26][CH:25]=[C:24]([C:28]([O:30]CC)=[O:29])[CH:23]=3)[O:8][C:7]=2[CH:6]=[CH:5][CH:4]=1.[Li+].[OH-].Cl.C(OCC)(=O)C', 'C1COCC1.C(O)C', '[CH3:1][O:2][C:3]1[C:12]2[C:11]3[CH:13]=[CH:14][C:15]([CH2:17][S:18]([NH2:21])(=[O:20])=[O:19])=[CH:16][C:10]=3[CH:9]([C:22]3[CH:27]=[CH:26][CH:25]=[C:24]([C:28]([OH:30])=[O:29])[CH:23]=3)[O:8][C:7]=2[CH:6]=[CH:5][CH:4]=1 |f:1.2|']","['US20010041802A1', '(1-methoxy-6-(3-carboxyphenyl)-6H-dibenzo(b,d)pyran-8-yl)methanesulfonamide', '0274', 'A solution of Example 51 (0.34 g, 0.76 mmol) in THF (5 mL) and ethanol (5 mL) was treated with a solution of 10% LiOH (5 mL), stirred at room temperature for 20 hours, and poured into a mixture of ice, 1M HCl (50 mL) and ethyl acetate (50 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate. The extract was dried (Na2SO4), filtered, and concentrated to provide the desired product.(0.26 g, 80%) as a white solid MS (ESI(−)Q1MS) m/z 424 (M-H)−.']","[{'chemical_names': ['solution', '(1-methoxy-6-(3-carboethoxyphenyl)-6H-dibenzo(b,d)pyran-8-yl)methanesulfonamide'], 'identifiers': ['smiles:CCOC(=O)c1cccc(C2Oc3cccc(OC)c3-c3ccc(CS(N)(=O)=O)cc32)c1', 'inchi:InChI=1S/C24H23NO6S/c1-3-30-24(26)17-7-4-6-16(13-17)23-19-12-15(14-32(25,27)28)10-11-18(19)22-20(29-2)8-5-9-21(22)31-23/h4-13,23H,3,14H2,1-2H3,(H2,25,27,28)'], 'amounts': ['0.76 mmol', '0.34 g'], 'appearances': []}, {'chemical_names': ['LiOH'], 'identifiers': ['smiles:[Li+].[OH-]', 'inchi:InChI=1S/Li.H2O/h;1H2/q+1;/p-1'], 'amounts': ['5 mL'], 'appearances': []}, {'chemical_names': ['HCl'], 'identifiers': ['smiles:Cl', 'inchi:InChI=1S/ClH/h1H'], 'amounts': ['1M', '50 mL'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['50 mL'], 'appearances': []}]","[{'chemical_names': ['desired product', '(1-methoxy-6-(3-carboxyphenyl)-6H-dibenzo(b,d)pyran-8-yl)methanesulfonamide'], 'identifiers': ['smiles:COc1cccc2c1-c1ccc(CS(N)(=O)=O)cc1C(c1cccc(C(=O)O)c1)O2', 'inchi:InChI=1S/C22H19NO6S/c1-28-18-6-3-7-19-20(18)16-9-8-13(12-30(23,26)27)10-17(16)21(29-19)14-4-2-5-15(11-14)22(24)25/h2-11,21H,12H2,1H3,(H,24,25)(H2,23,26,27)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['5 mL'], 'appearances': []}, {'chemical_names': ['ethanol'], 'identifiers': ['smiles:CCO', 'inchi:InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3'], 'amounts': ['5 mL'], 'appearances': []}]",[],"['step 1:A solution of Example 51 (0.34 g, 0.76 mmol) in THF (5 mL) and ethanol (5 mL) was treated with a solution of 10% LiOH (5 mL)', 'step 2:stirred at room temperature for 20 hours', 'step 2 properties:Time:72000', 'step 2 properties:Temperature:room temperature', 'step 3:poured into a mixture of ice, 1M HCl (50 mL) and ethyl acetate (50 mL)', 'step 4:The layers were separated', 'step 5:the aqueous layer was extracted with ethyl acetate', 'step 6:The extract was dried (Na2SO4)', 'step 7:filtered', 'step 8:concentrated', 'step 9:to provide the desired product']"
"['[CH3:1][O:2][C:3]1[CH:8]=[CH:7][CH:6]=[C:5](OCOC)[C:4]=1[C:13]1[C:18]([CH:19]([OH:26])[C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][N:21]=2)=[CH:17][C:16]([CH2:27][S:28]([NH2:31])(=[O:30])=[O:29])=[CH:15][CH:14]=1.C(P(CCCC)CCCC)CCC.N(C(N1CCCCC1)=O)=NC(N1CCCCC1)=O.[Na+].[Cl-]', 'C1COCC1.C(OCC)(=O)C', '[CH3:1][O:2][C:3]1[C:4]2[C:13]3[CH:14]=[CH:15][C:16]([CH2:27][S:28]([NH2:31])(=[O:30])=[O:29])=[CH:17][C:18]=3[CH:19]([C:20]3[CH:25]=[CH:24][CH:23]=[CH:22][N:21]=3)[O:26][C:5]=2[CH:6]=[CH:7][CH:8]=1 |f:3.4|']","['US20010041802A1', '(1-methoxy-6-(2-pyridyl)-6H-dibenzo(b,d)pyran-8-yl)methanesulfonamide', '0280', 'A solution of (4-(2-methoxy-6-methoxymethoxyphenyl)-5-(1-hydroxy-1-(2-pyridyl)methyl)phenyl methanesulfonamide (0.030 g, 0.075 mmol), prepared according to the procedures of Examples 32A-F, in THF (1 mL) was treated with tributylphoshine (0.045 g, 0.23 mmol) and 1,1′-(azodicarbonyl)dipiperidine (0.057 g, 0.23 mmol), stirred for 4 hours at room temperature, and treated with saturated NaCl (10 mL) and ethyl acetate (10 mL) to provide two layers. The layers were separated, and the aqueous layer was extracted with ethyl acetate. The extract was dried (Na2SO4), filtered, and concentrated. The concentrate was purified by reverse phase HPLC with 20-100% CH3CN/water to provide the desired product. MS (ESI(−)Q1MS) m/z 381 (M-H)−; 1H NMR (300 MHz, DMSO-d6) δ 9.83 (s, 1H), 8.53 (m, 1H), 8.31 (d, J=8 Hz, 1H), 7.79 (dt, J=8 Hz, 2 Hz, 1H), 7.39 (d, J=8 Hz, 1H), 7.32 (m, 1H), 7.22 (m, 1H), 7.18 (d, J=8 Hz, 1H), 6.93 (d, J=2 Hz, 1H), 6.75 (d, J=8 Hz, 1H), 6.70 (d, J=8 Hz, 1H), 6.21 (s, 1H), 3.90 (s, 3H), 3.00 (s, 3H).']","[{'chemical_names': ['4-(2-methoxy-6-methoxymethoxyphenyl)-5-(1-hydroxy-1-(2-pyridyl)methyl)phenyl methanesulfonamide'], 'identifiers': ['smiles:COCOc1cccc(OC)c1-c1ccc(CS(N)(=O)=O)cc1C(O)c1ccccn1', 'inchi:InChI=1S/C22H24N2O6S/c1-28-14-30-20-8-5-7-19(29-2)21(20)16-10-9-15(13-31(23,26)27)12-17(16)22(25)18-6-3-4-11-24-18/h3-12,22,25H,13-14H2,1-2H3,(H2,23,26,27)'], 'amounts': ['0.075 mmol', '0.030 g'], 'appearances': []}, {'chemical_names': ['tributylphoshine'], 'identifiers': ['smiles:CCCCP(CCCC)CCCC', 'inchi:InChI=1S/C12H27P/c1-4-7-10-13(11-8-5-2)12-9-6-3/h4-12H2,1-3H3'], 'amounts': ['0.23 mmol', '0.045 g'], 'appearances': []}, {'chemical_names': ['1,1′-(azodicarbonyl)dipiperidine'], 'identifiers': ['smiles:O=C(N=NC(=O)N1CCCCC1)N1CCCCC1', 'inchi:InChI=1S/C12H20N4O2/c17-11(15-7-3-1-4-8-15)13-14-12(18)16-9-5-2-6-10-16/h1-10H2'], 'amounts': ['0.23 mmol', '0.057 g'], 'appearances': []}, {'chemical_names': ['NaCl'], 'identifiers': ['smiles:[Cl-].[Na+]', 'inchi:InChI=1S/ClH.Na/h1H;/q;+1/p-1'], 'amounts': ['10 mL'], 'appearances': []}]","[{'chemical_names': ['desired product', '(1-methoxy-6-(2-pyridyl)-6H-dibenzo(b,d)pyran-8-yl)methanesulfonamide'], 'identifiers': ['smiles:COc1cccc2c1-c1ccc(CS(N)(=O)=O)cc1C(c1ccccn1)O2', 'inchi:InChI=1S/C20H18N2O4S/c1-25-17-6-4-7-18-19(17)14-9-8-13(12-27(21,23)24)11-15(14)20(26-18)16-5-2-3-10-22-16/h2-11,20H,12H2,1H3,(H2,21,23,24)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['1 mL'], 'appearances': []}, {'chemical_names': ['ethyl acetate'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['10 mL'], 'appearances': []}]",[],"['step 1:A solution of (4-(2-methoxy-6-methoxymethoxyphenyl)-5-(1-hydroxy-1-(2-pyridyl)methyl)phenyl methanesulfonamide (0.030 g, 0.075 mmol), prepared', 'step 2:was treated with tributylphoshine (0.045 g, 0.23 mmol) and 1,1′-(azodicarbonyl)dipiperidine (0.057 g, 0.23 mmol)', 'step 3:stirred for 4 hours at room temperature', 'step 3 properties:Time:14400', 'step 3 properties:Temperature:room temperature', 'step 4:treated with saturated NaCl (10 mL) and ethyl acetate (10 mL)', 'step 5:to provide two layers', 'step 6:The layers were separated', 'step 7:the aqueous layer was extracted with ethyl acetate', 'step 8:The extract was dried (Na2SO4)', 'step 9:filtered', 'step 10:concentrated', 'step 11:The concentrate was purified by reverse phase HPLC with 20-100% CH3CN/water', 'step 12:to provide the desired product']"
"['COC1C=[CH:11][CH:10]=[C:9]2[C:4]=1[C:5]1[CH:26]=[CH:25][C:24]([NH:27][S:28]([CH3:31])(=[O:30])=[O:29])=[CH:23][C:6]=1[CH:7]([C:13]1[CH:18]=[CH:17][CH:16]=[C:15]([O:19][CH2:20][CH:21]=O)[CH:14]=1)[O:8]2.[Br-].[CH3:33][O:34][CH2:35][CH2:36][PH3+].[OH-].[Na+].C1[CH2:44][O:43][CH2:42][CH2:41]1', 'CCOC(C)=O.[Cl-].[Na+].O', '[CH3:33][O:34][C:35]1[CH:36]=[CH:11][CH:10]=[C:9]2[C:4]=1[C:5]1[CH:26]=[CH:25][C:24]([NH:27][S:28]([CH3:31])(=[O:29])=[O:30])=[CH:23][C:6]=1[CH:7]([C:13]1[CH:18]=[CH:17][CH:16]=[C:15]([O:19][CH2:20][CH2:21][CH2:41][CH2:42][O:43][CH3:44])[CH:14]=1)[O:8]2 |f:1.2,3.4,7.8.9|']","['US20010041802A1', 'N-{1-methoxy-6-[3-(4-methoxybutoxy)phenyl]-6H-benzo[c]chromen-8-yl}methanesulfonamide', '0310', 'A solution of Example 94A (0.05 g, 0.114 mmol), methoxyethylphosphonium bromide (0.068 g, 0.171 mmol) and aqueous sodium hydroxide (1 mL, 6.0M) in THF (1 mL) was stirred for 16 hours, and then diluted with EtOAc (10 mL) and brine (25 mL). The layers were separated and the organic layer was dried (Na2SO4), filtered and concentrated under reduced pressure. The residue and 10% Pd on carbon (0.005 g) in anhydrous THF (2 mL) were shaken under hydrogen gas (balloon) for 6 hours. The mixture was filtered through diatomaceous earth (Celite®), washing the filtrant with dry TUF (2×20 mL). The combined organics were concentrated under reduced pressure and purified by HPLC using 0.1% TFA and MeCN to provide the titled compound (1H NMR (300 MHz, DMSO-d6) δ 9.84 (s, 1H), 8.33 (d, J=9 Hz, 1H), 7.26-7.22 (m, 2H), 7.15 (t, J=8 Hz, 1H), 6.92-6.80 (m, 4H), 6.73 (d, J=8 Hz, 1H), 6.65 (d, J=9 Hz, 1H), 6.18 (s, 1H), 3.89 (t, J=6 Hz, 2H), 3.88 (s, 3H), 3.46-3.43 (m, 2H), 3.21 (s, 3H), 3.00 (s, 3H), 1.71-1.57 (m, 4H); MS (ESI, −Q1MS) m/e 508 (M-H).']","[{'chemical_names': ['solution', 'N-{1-methoxy-6-[3-(2-oxoethoxy)phenyl]-6H-benzo[c]chromen-8-yl}methanesulfonamide'], 'identifiers': ['smiles:COc1cccc2c1-c1ccc(NS(C)(=O)=O)cc1C(c1cccc(OCC=O)c1)O2', 'inchi:InChI=1S/C23H21NO6S/c1-28-20-7-4-8-21-22(20)18-10-9-16(24-31(2,26)27)14-19(18)23(30-21)15-5-3-6-17(13-15)29-12-11-25/h3-11,13-14,23-24H,12H2,1-2H3'], 'amounts': ['0.114 mmol', '0.05 g'], 'appearances': []}, {'chemical_names': ['methoxyethylphosphonium bromide'], 'identifiers': ['smiles:COCC[PH3+].[Br-]', 'inchi:InChI=1S/C3H9OP.BrH/c1-4-2-3-5;/h2-3,5H2,1H3;1H'], 'amounts': ['0.171 mmol', '0.068 g'], 'appearances': []}, {'chemical_names': ['sodium hydroxide'], 'identifiers': ['smiles:[Na+].[OH-]', 'inchi:InChI=1S/Na.H2O/h;1H2/q+1;/p-1'], 'amounts': ['6.0M', '1 mL'], 'appearances': []}, {'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['1 mL'], 'appearances': []}]","[{'chemical_names': ['titled compound', 'N-{1-methoxy-6-[3-(4-methoxybutoxy)phenyl]-6H-benzo[c]chromen-8-yl}methanesulfonamide'], 'identifiers': ['smiles:COCCCCOc1cccc(C2Oc3cccc(OC)c3-c3ccc(NS(C)(=O)=O)cc32)c1', 'inchi:InChI=1S/C26H29NO6S/c1-30-14-4-5-15-32-20-9-6-8-18(16-20)26-22-17-19(27-34(3,28)29)12-13-21(22)25-23(31-2)10-7-11-24(25)33-26/h6-13,16-17,26-27H,4-5,14-15H2,1-3H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['EtOAc'], 'identifiers': ['smiles:CCOC(C)=O', 'inchi:InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3'], 'amounts': ['10 mL'], 'appearances': []}, {'chemical_names': ['brine'], 'identifiers': ['smiles:O.[Cl-].[Na+]', 'inchi:InChI=1S/ClH.Na.H2O/h1H;;1H2/q;+1;/p-1'], 'amounts': ['25 mL'], 'appearances': []}]",[],"['step 1:A solution of Example 94A (0.05 g, 0.114 mmol), methoxyethylphosphonium bromide (0.068 g, 0.171 mmol) and aqueous sodium hydroxide (1 mL, 6.0M) in THF (1 mL) was stirred for 16 hours', 'step 1 properties:Time:57600', 'step 2:diluted with EtOAc (10 mL) and brine (25 mL)', 'step 3:The layers were separated', 'step 4:the organic layer was dried (Na2SO4)', 'step 5:filtered', 'step 6:concentrated under reduced pressure', 'step 6 properties:Pressure:reduced pressure', 'step 7:The residue and 10% Pd on carbon (0.005 g) in anhydrous THF (2 mL) were shaken under hydrogen gas (balloon) for 6 hours', 'step 7 properties:Time:21600', 'step 8:The mixture was filtered through diatomaceous earth (Celite®)', 'step 9:washing the filtrant', 'step 10:with dry TUF (2×20 mL)', 'step 11:The combined organics were concentrated under reduced pressure', 'step 11 properties:Pressure:reduced pressure', 'step 12:purified by HPLC', 'step 13:to provide the titled compound (1H NMR (300 MHz, DMSO-d6) δ 9.84 (s, 1H), 8.33 (d, J=9 Hz, 1H), 7.26-7.22 (m, 2H), 7.15 (t, J=8 Hz, 1H), 6.92-6.80 (m, 4H), 6.73 (d, J=8 Hz, 1H), 6.65 (d, J=9 Hz, 1H), 6.18 (s, 1H), 3.89 (t, J=6 Hz, 2H), 3.88 (s, 3H), 3.46-3.43 (m, 2H), 3.21 (s, 3H), 3.00 (s, 3H), 1.71-1.57 (m, 4H)']"
